{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T15:20:44Z","timestamp":1793892044967,"version":"4.8.0"},"reference-count":239,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Science and Technology Department Public Welfare Project of Zhejiang Province","award":["LGF22H160032"],"award-info":[{"award-number":["LGF22H160032"]}]},{"DOI":"10.13039\/501100017594","name":"Medical and Health Science and Technology Project of Zhejiang Province","doi-asserted-by":"crossref","award":["2022RC107 and 2023KY501"],"award-info":[{"award-number":["2022RC107 and 2023KY501"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-06629-6","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T09:04:49Z","timestamp":1748855089000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Unraveling the advances of non-coding RNAs on the tumor microenvironment: innovative strategies for cancer therapies"],"prefix":"10.1186","volume":"23","author":[{"given":"Deyang","family":"Mu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jungang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,2]]},"reference":[{"key":"6629_CR1","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1158\/2159-8290.CD-20-1808","volume":"11","author":"L Bejarano","year":"2021","unstructured":"Bejarano L, Jord\u0101o MJC, Joyce JA. Therapeutic targeting of the tumor microenvironment. Cancer Discov. 2021;11:933\u201359.","journal-title":"Cancer Discov"},{"key":"6629_CR2","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jhep.2023.10.006","volume":"80","author":"L Zhang","year":"2024","unstructured":"Zhang L, Xu J, Zhou S, Yao F, Zhang R, You W, Dai J, Yu K, Zhang Y, Baheti T, Pu L, Xu J, Qian X, Zhang C, Xia Y, Dai X, Li Q, Wang X. Endothelial DGKG promotes tumor angiogenesis and immune evasion in hepatocellular carcinoma. J Hepatol. 2024;80:82\u201398.","journal-title":"J Hepatol"},{"key":"6629_CR3","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12943-022-01645-2","volume":"21","author":"R Bai","year":"2022","unstructured":"Bai R, Li Y, Jian L, Yang Y, Zhao L, Wei M. The hypoxia-driven crosstalk between tumor and tumor-associated macrophages: mechanisms and clinical treatment strategies. Mol Cancer. 2022;21:177.","journal-title":"Mol Cancer"},{"key":"6629_CR4","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1016\/j.ymthe.2022.01.046","volume":"30","author":"Z Xu","year":"2022","unstructured":"Xu Z, Chen Y, Ma L, Chen Y, Liu J, Guo Y, Yu T, Zhang L, Zhu L, Shu Y. Role of Exosomal non-coding RNAs from tumor cells and tumor-associated macrophages in the tumor microenvironment. Mol Therapy: J Am Soc Gene Therapy. 2022;30:3133\u201354.","journal-title":"Mol Therapy: J Am Soc Gene Therapy"},{"key":"6629_CR5","doi-asserted-by":"publisher","first-page":"847728","DOI":"10.3389\/fimmu.2022.847728","volume":"13","author":"C Xue","year":"2022","unstructured":"Xue C, Gu X, Bao Z, Su Y, Lu J, Li L. The mechanism underlying the NcRNA dysregulation pattern in hepatocellular carcinoma and its tumor microenvironment. Front Immunol. 2022;13:847728.","journal-title":"Front Immunol"},{"key":"6629_CR6","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1186\/s12967-023-04370-6","volume":"21","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Fan X, Zhang X, Ju S. Ferroptosis in tumors and its relationship to other programmed cell death: role of non-coding RNAs. J Translational Med. 2023;21:514.","journal-title":"J Translational Med"},{"key":"6629_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13046-020-01798-2","volume":"40","author":"Y Liu","year":"2021","unstructured":"Liu Y, Liu X, Lin C, Jia X, Zhu H, Song J, Zhang Y. Noncoding RNAs regulate alternative splicing in Cancer. J Experimental Clin cancer Research: CR. 2021;40:11.","journal-title":"J Experimental Clin cancer Research: CR"},{"key":"6629_CR8","doi-asserted-by":"publisher","first-page":"8665","DOI":"10.3390\/ijms25168665","volume":"25","author":"C Wei","year":"2024","unstructured":"Wei C, Zhang C, Zhou Y, Wang J, Jin Y. Progress of Exosomal LncRNAs in pancreatic Cancer. Int J Mol Sci. 2024;25:8665.","journal-title":"Int J Mol Sci"},{"key":"6629_CR9","doi-asserted-by":"publisher","first-page":"713","DOI":"10.4149\/neo_2023_230711N362","volume":"70","author":"T Gao","year":"2023","unstructured":"Gao T, Lin YQ, Ye HY, Lin WM. miR-124 delivered by BM-MSCs-derived exosomes targets MCT1 of tumor-infiltrating Treg cells and improves ovarian cancer immunotherapy. Neoplasma. 2023;70:713\u201321.","journal-title":"Neoplasma"},{"key":"6629_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41392-020-0129-7","volume":"5","author":"C Ni","year":"2020","unstructured":"Ni C, Fang QQ, Chen WZ, Jiang JX, Jiang Z, Ye J, Zhang T, Yang L, Meng FB, Xia WJ, Zhong M, Huang J. Breast cancer-derived exosomes transmit LncRNA SNHG16 to induce CD73+\u03b3\u03b41 Treg cells. Signal Transduct Target Therapy. 2020;5:41.","journal-title":"Signal Transduct Target Therapy"},{"key":"6629_CR11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12929-023-00964-w","volume":"30","author":"HM Nail","year":"2023","unstructured":"Nail HM, Chiu CC, Leung CH, Ahmed MMM, Wang HD. Exosomal miRNA-mediated intercellular communications and Immunomodulatory effects in tumor microenvironments. J Biomed Sci. 2023;30:69.","journal-title":"J Biomed Sci"},{"key":"6629_CR12","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s13046-022-02433-y","volume":"41","author":"Y Lv","year":"2022","unstructured":"Lv Y, Lv Y, Wang Z, Yuan K, Zeng Y. Noncoding RNAs as sensors of tumor microenvironmental stress. J Experimental Clin cancer Research: CR. 2022;41:224.","journal-title":"J Experimental Clin cancer Research: CR"},{"key":"6629_CR13","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.1111\/cas.15372","volume":"113","author":"H Xu","year":"2022","unstructured":"Xu H, Li M, Pan Z, Zhang Z, Gao Z, Zhao R, Li B, Qi Y, Qiu W, Guo Q, Zhang S, Fan Y, Zhao S, Wang S, Guo X, Deng L, Xue H, Li G. miR-3184-3p enriched in cerebrospinal fluid exosomes contributes to progression of glioma and promotes M2-like macrophage polarization. Cancer Sci. 2022;113:2668\u201380.","journal-title":"Cancer Sci"},{"key":"6629_CR14","doi-asserted-by":"publisher","first-page":"104774","DOI":"10.1016\/j.jprot.2022.104774","volume":"272","author":"T Lima","year":"2023","unstructured":"Lima T, Rodrigues JE, Manadas B, Henrique R, Fardilha M, Vitorino R. A peptide-centric approach to analyse quantitative proteomics data- an application to prostate cancer biomarker discovery. J Proteom. 2023;272:104774.","journal-title":"J Proteom"},{"issue":"4","key":"6629_CR15","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s11427-019-1658-x","volume":"63","author":"X Li","year":"2020","unstructured":"Li X, Liang QX, Lin JR, Peng J, Yang JH, Yi C, Yu Y, Zhang QC, Zhou KR. Epitranscriptomic technologies and analyses. Sci China Life Sci. 2020;63(4):501\u201315.","journal-title":"Sci China Life Sci"},{"issue":"2","key":"6629_CR16","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.tig.2021.06.014","volume":"38","author":"RL Kan","year":"2022","unstructured":"Kan RL, Chen J, Sallam T. Crosstalk between epitranscriptomic and epigenetic mechanisms in gene regulation. Trends Genet. 2022;38(2):182\u201393.","journal-title":"Trends Genet"},{"issue":"3","key":"6629_CR17","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ccell.2020.02.004","volume":"37","author":"H Huang","year":"2020","unstructured":"Huang H, Weng H, Chen J. m6A modification in coding and Non-coding RNAs: roles and therapeutic implications in Cancer. Cancer Cell. 2020;37(3):270\u201388.","journal-title":"Cancer Cell"},{"key":"6629_CR18","doi-asserted-by":"publisher","first-page":"22322","DOI":"10.1038\/s41598-022-26894-5","volume":"12","author":"P Qiu","year":"2022","unstructured":"Qiu P, Guo Q, Lin J, Pan K, Chen J, Ding M. An exosome-related long non-coding RNAs risk model could predict survival outcomes in patients with breast cancer. Sci Rep. 2022;12:22322.","journal-title":"Sci Rep"},{"key":"6629_CR19","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/s41419-021-03680-1","volume":"12","author":"SJ Yang","year":"2021","unstructured":"Yang SJ, Wang DD, Zhong SL, Chen WQ, Wang FL, Zhang J, Xu WX, Xu D, Zhang Q, Li J, Zhang HD, Hou JC, Mao L, Tang JH. Tumor-derived Exosomal circPSMA1 facilitates the tumorigenesis, metastasis, and migration in triple-negative breast cancer (TNBC) through miR-637\/Akt1\/\u03b2-catenin (cyclin D1) axis. Cell Death Dis. 2021;12:420.","journal-title":"Cell Death Dis"},{"key":"6629_CR20","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.7150\/thno.83920","volume":"13","author":"M Liu","year":"2023","unstructured":"Liu M, Zhang S, Zhou H, Hu X, Li J, Fu B, Wei M, Huang H, Wu H. The interplay between non-coding RNAs and alternative splicing: from regulatory mechanism to therapeutic implications in cancer. Theranostics. 2023;13:2616\u201331.","journal-title":"Theranostics"},{"key":"6629_CR21","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12929-024-01047-0","volume":"31","author":"K Wen","year":"2024","unstructured":"Wen K, Chen X, Gu J, Chen Z, Wang Z. Beyond traditional translation: NcRNA derived peptides as modulators of tumor behaviors. J Biomed Sci. 2024;31:63.","journal-title":"J Biomed Sci"},{"key":"6629_CR22","doi-asserted-by":"publisher","first-page":"e1754","DOI":"10.1002\/wrna.1754","volume":"14","author":"J Balakittnen","year":"2023","unstructured":"Balakittnen J, Weeramange CE, Wallace DF, Duijf PHG, Cristino AS, Kenny L, Vasani S, Punyadeera C. Noncoding RNAs in oral cancer. Wiley Interdisciplinary Reviews RNA. 2023;14:e1754.","journal-title":"Wiley Interdisciplinary Reviews RNA"},{"key":"6629_CR23","doi-asserted-by":"publisher","first-page":"3943","DOI":"10.7150\/thno.83178","volume":"13","author":"C Chai","year":"2023","unstructured":"Chai C, Sui K, Tang J, Yu H, Yang C, Zhang H, Li SC, Zhong JF, Wang Z, Zhang X. BCR-ABL1-driven exosome-miR130b-3p-mediated gap-junction Cx43 MSC intercellular communications imply therapies of leukemic subclonal evolution. Theranostics. 2023;13:3943\u201363.","journal-title":"Theranostics"},{"key":"6629_CR24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13046-022-02244-1","volume":"41","author":"X Li","year":"2022","unstructured":"Li X, Wang S, Mu W, Barry J, Han A, Carpenter RL, Jiang BH, Peiper SC, Mahoney MG, Aplin AE, Ren H, He J. Reactive oxygen species reprogram macrophages to suppress antitumor immune response through the Exosomal miR-155-5p\/PD-L1 pathway. J Experimental Clin cancer Research: CR. 2022;41:41.","journal-title":"J Experimental Clin cancer Research: CR"},{"key":"6629_CR25","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13048-023-01157-7","volume":"16","author":"H Wang","year":"2023","unstructured":"Wang H, Liu L, Liu Q, Zheng J, Zheng Q, Chen Y, Xia H, Wu Q, Sun Y. Identification of upregulated Exosomal MiRNAs between A2780 and A2780\/DDP human ovarian cancer cells by high-throughput sequencing. J Ovarian Res. 2023;16:94.","journal-title":"J Ovarian Res"},{"key":"6629_CR26","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00018-022-04229-x","volume":"79","author":"L Lu","year":"2022","unstructured":"Lu L, Li J, Wei R, Guidi I, Cozzuto L, Ponomarenko J, Prats-Ejarque G, Boix E. Selective cleavage of NcRNA and antiviral activity by RNase2\/EDN in THP1-induced macrophages. Cell Mol Life Sci. 2022;79:209.","journal-title":"Cell Mol Life Sci"},{"key":"6629_CR27","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41392-022-00975-3","volume":"7","author":"B Chen","year":"2022","unstructured":"Chen B, Dragomir MP, Yang C, Li Q, Horst D, Calin GA. Targeting non-coding RNAs to overcome cancer therapy resistance. Signal Transduct Target Therapy. 2022;7:121.","journal-title":"Signal Transduct Target Therapy"},{"key":"6629_CR28","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1111\/1751-7915.13565","volume":"13","author":"X Wang","year":"2020","unstructured":"Wang X, Yao X, Xie T, Chang Z, Guo Y, Ni H. Exosome-derived uterine miR-218 isolated from cows with endometritis regulates the release of cytokines and chemokines. Microb Biotechnol. 2020;13:1103\u201317.","journal-title":"Microb Biotechnol"},{"key":"6629_CR29","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12943-021-01396-6","volume":"20","author":"XH Tang","year":"2021","unstructured":"Tang XH, Guo T, Gao XY, Wu XL, Xing XF, Ji JF, Li ZY. Exosome-derived noncoding RNAs in gastric cancer: functions and clinical applications. Mol Cancer. 2021;20:99.","journal-title":"Mol Cancer"},{"key":"6629_CR30","doi-asserted-by":"publisher","first-page":"102449","DOI":"10.1016\/j.apmt.2024.102449","volume":"41","author":"M Safarkhani","year":"2024","unstructured":"Safarkhani M, Dana N, Taghavimandi F, Najaflu M, Esmaeili Y, Nazarzadeh Zare E, Huh YS, Rahimmanesh I, Makvandi P, Xu Y, Jin X. Exploring metal-organic frameworks in gene delivery: from prostate to lung therapeutics. Appl Mater Today. 2024;41:102449.","journal-title":"Appl Mater Today"},{"key":"6629_CR31","first-page":"188491","volume":"1875","author":"S Toden","year":"2021","unstructured":"Toden S, Zumwalt TJ, Goel A. Non-coding RNAs and potential therapeutic targeting in cancer. Biochimica et biophysica acta. Reviews cancer. 2021;1875:188491.","journal-title":"Reviews cancer"},{"key":"6629_CR32","doi-asserted-by":"publisher","first-page":"1121390","DOI":"10.3389\/fendo.2023.1121390","volume":"14","author":"IR Siqueira","year":"2023","unstructured":"Siqueira IR, Batabyal RA, Freishtat R, Cechinel LR. Potential involvement of Circulating extracellular vesicles and particles on exercise effects in malignancies. Front Endocrinol. 2023;14:1121390.","journal-title":"Front Endocrinol"},{"key":"6629_CR33","doi-asserted-by":"crossref","unstructured":"Qi, Y., Jin, C., Qiu, W., Zhao, R., Wang, S., Li, B., Zhang, Z., Guo, Q., Zhang, S.,Gao, Z., Zhao, S., Pan, Z., Fan, Y., Chen, Z., Wang, H., Xu, J., Deng, L., Ni, S.,Wang, J., Xue, H.,\u2026 Li, G. (2022). The dual role of glioma exosomal microRNAs: glioma eliminates tumor suppressor miR-1298-5p via exosomes to promote immunosuppressive effects of MDSCs. Cell death & disease, 13, 426.","DOI":"10.1038\/s41419-022-04872-z"},{"key":"6629_CR34","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/s41419-022-05270-1","volume":"13","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Dhani S, Zhivotovsky B. Unveiling caspase-2 regulation by non-coding RNAs. Cell Death Dis. 2022;13:834.","journal-title":"Cell Death Dis"},{"key":"6629_CR35","doi-asserted-by":"publisher","first-page":"15455","DOI":"10.1038\/s41598-021-94671-x","volume":"11","author":"T Katopodi","year":"2021","unstructured":"Katopodi T, Petanidis S, Domvri K, Zarogoulidis P, Anestakis D, Charalampidis C, Tsavlis D, Bai C, Huang H, Freitag L, Hohenforst-Schmidt W, Matthaios D, Porpodis K. Kras-driven intratumoral heterogeneity triggers infiltration of M2 polarized macrophages via the circHIPK3\/PTK2 immunosuppressive circuit. Sci Rep. 2021;11:15455.","journal-title":"Sci Rep"},{"key":"6629_CR36","doi-asserted-by":"publisher","first-page":"156847","DOI":"10.1016\/j.cej.2024.156847","volume":"506","author":"M Safarkhani","year":"2025","unstructured":"Safarkhani M, Taghavimandi F, Biglari N, Ojaghi A, Naderi Farzan F, Shin K, Won J, Xu Y, Huh Y, Zare N, E., Makvandi P. Metal-organic frameworks integrated into carbohydrate polymers as promising platforms for tissue engineering. Chem Eng J. 2025;506:156847.","journal-title":"Chem Eng J"},{"key":"6629_CR37","doi-asserted-by":"publisher","first-page":"1307455","DOI":"10.3389\/fimmu.2023.1307455","volume":"14","author":"R Zhang","year":"2023","unstructured":"Zhang R, Wei Y, Wang T, Nie X, Shi Z, Deng Y, Li D. Exosomal MiRNAs in autoimmune skin diseases. Front Immunol. 2023;14:1307455.","journal-title":"Front Immunol"},{"key":"6629_CR38","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/nrg.2017.6","volume":"18","author":"L Adams","year":"2017","unstructured":"Adams L. Non-coding RNA: Pri-miRNA processing: structure is key. Nat Rev Genet. 2017;18:145.","journal-title":"Nat Rev Genet"},{"key":"6629_CR39","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/nature14281","volume":"519","author":"CR Alarc\u00f3n","year":"2015","unstructured":"Alarc\u00f3n CR, Lee H, Goodarzi H, Halberg N, Tavazoie SF. N6-methyladenosine marks primary MicroRNAs for processing. Nature. 2015;519:482\u20135.","journal-title":"Nature"},{"key":"6629_CR40","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/s41576-023-00611-y","volume":"24","author":"R Shang","year":"2023","unstructured":"Shang R, Lee S, Senavirathne G, Lai EC. MicroRNAs in action: biogenesis, function and regulation. Nat Rev Genet. 2023;24:816\u201333.","journal-title":"Nat Rev Genet"},{"key":"6629_CR41","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.omtn.2021.07.021","volume":"25","author":"DW Binzel","year":"2021","unstructured":"Binzel DW, Guo S, Yin H, Lee TJ, Liu S, Shu D, Guo P. Rational design for controlled release of Dicer-substrate SiRNA harbored in phi29 pRNA-based nanoparticles. Mol Therapy Nucleic Acids. 2021;25:524\u201335.","journal-title":"Mol Therapy Nucleic Acids"},{"key":"6629_CR42","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41586-023-05723-3","volume":"615","author":"YY Lee","year":"2023","unstructured":"Lee YY, Lee H, Kim H, Kim VN, Roh SH. Structure of the human DICER-pre-miRNA complex in a dicing state. Nature. 2023;615:331\u20138.","journal-title":"Nature"},{"key":"6629_CR43","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1093\/nar\/gkad1142","volume":"52","author":"C Diener","year":"2024","unstructured":"Diener C, Keller A, Meese E. The miRNA-target interactions: an underestimated intricacy. Nucleic Acids Res. 2024;52:1544\u201357.","journal-title":"Nucleic Acids Res"},{"key":"6629_CR44","first-page":"5","volume":"20","author":"T Treiber","year":"2019","unstructured":"Treiber T, Treiber N, Meister G. Regulation of MicroRNA biogenesis and its crosstalk with other cellular pathways. Nature reviews. Mol Cell Biology. 2019;20:5\u201320.","journal-title":"Mol Cell Biology"},{"key":"6629_CR45","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nrm3838","volume":"15","author":"M Ha","year":"2014","unstructured":"Ha M, Kim VN. Regulation of MicroRNA biogenesis. Nat Rev Mol Cell Biol. 2014;15:509\u201324.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"6629_CR46","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1016\/j.molcel.2020.04.030","volume":"78","author":"H Kim","year":"2020","unstructured":"Kim H, Kim J, Yu S, Lee YY, Park J, Choi RJ, Yoon SJ, Kang SG, Kim VN. A mechanism for MicroRNA arm switching regulated by uridylation. Mol Cell. 2020;78:1224\u2013e12365.","journal-title":"Mol Cell"},{"key":"6629_CR47","doi-asserted-by":"publisher","first-page":"eaav1741","DOI":"10.1126\/science.aav1741","volume":"366","author":"SE McGeary","year":"2019","unstructured":"McGeary SE, Lin KS, Shi CY, Pham TM, Bisaria N, Kelley GM, Bartel DP. The biochemical basis of MicroRNA targeting efficacy. Sci (New York N Y). 2019;366:eaav1741.","journal-title":"Sci (New York N Y)"},{"key":"6629_CR48","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.molcel.2018.02.012","volume":"69","author":"JK Nussbacher","year":"2018","unstructured":"Nussbacher JK, Yeo GW. Systematic discovery of RNA binding proteins that regulate MicroRNA levels. Mol Cell. 2018;69:1005\u2013e10167.","journal-title":"Mol Cell"},{"key":"6629_CR49","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/j.molcel.2024.02.005","volume":"84","author":"SC Baek","year":"2024","unstructured":"Baek SC, Kim B, Jang H, Kim K, Park IS, Min DH, Kim VN. Structural atlas of human primary MicroRNAs generated by SHAPE-MaP. Mol Cell. 2024;84:1158\u2013e11726.","journal-title":"Mol Cell"},{"key":"6629_CR50","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1038\/s41467-018-04871-9","volume":"9","author":"H Kooshapur","year":"2018","unstructured":"Kooshapur H, Choudhury NR, Simon B, M\u00fchlbauer M, Jussupow A, Fernandez N, Jones AN, Dallmann A, Gabel F, Camilloni C, Michlewski G, Caceres JF, Sattler M. Structural basis for terminal loop recognition and stimulation of pri-miRNA-18a processing by HnRNP A1. Nat Commun. 2018;9:2479.","journal-title":"Nat Commun"},{"key":"6629_CR51","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1093\/nar\/gkad1155","volume":"52","author":"KC Johnson","year":"2024","unstructured":"Johnson KC, Kilikevicius A, Hofman C, Hu J, Liu Y, Aguilar S, Graswich J, Han Y, Wang T, Westcott JM, Brekken RA, Peng L, Karagkounis G, Corey DR. Nuclear localization of argonaute 2 is affected by cell density and May relieve repression by MicroRNAs. Nucleic Acids Res. 2024;52:1930\u201352.","journal-title":"Nucleic Acids Res"},{"key":"6629_CR52","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1093\/nar\/gkae003","volume":"52","author":"AF Buhagiar","year":"2024","unstructured":"Buhagiar AF, Kleaveland B. To kill a MicroRNA: emerging concepts in target-directed MicroRNA degradation. Nucleic Acids Res. 2024;52:1558\u201374.","journal-title":"Nucleic Acids Res"},{"key":"6629_CR53","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.tibs.2018.09.012","volume":"44","author":"X Qian","year":"2019","unstructured":"Qian X, Zhao J, Yeung PY, Zhang QC, Kwok CK. Revealing LncRNA structures and interactions by Sequencing-Based approaches. Trends Biochem Sci. 2019;44:33\u201352.","journal-title":"Trends Biochem Sci"},{"key":"6629_CR54","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1038\/s41467-024-45517-3","volume":"15","author":"H Sharma","year":"2024","unstructured":"Sharma H, Valentine MNZ, Toki N, Sueki HN, Gustincich S, Takahashi H, Carninci P. Decryption of sequence, structure, and functional features of SINE repeat elements in SINEUP non-coding RNA-mediated post-transcriptional gene regulation. Nat Commun. 2024;15:1400.","journal-title":"Nat Commun"},{"key":"6629_CR55","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1038\/s41467-024-46509-z","volume":"15","author":"M Xu","year":"2024","unstructured":"Xu M, Senanayaka D, Zhao R, Chigumira T, Tripathi A, Tones J, Lackner RM, Wondisford AR, Moneysmith LN, Hirschi A, Craig S, Alishiri S, O\u2019Sullivan RJ, Chenoweth DM, Reiter NJ, Zhang H. TERRA-LSD1 phase separation promotes R-loop formation for telomere maintenance in ALT cancer cells. Nat Commun. 2024;15:2165.","journal-title":"Nat Commun"},{"key":"6629_CR56","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41421-024-00667-y","volume":"10","author":"X Liang","year":"2024","unstructured":"Liang X, Gong M, Wang Z, Wang J, Guo W, Cai A, Yang Z, Liu X, Xu F, Xiong W, Fu C, Wang X. LncRNA TubAR complexes with TUBB4A and TUBA1A to promote microtubule assembly and maintain myelination. Cell Discovery. 2024;10:54.","journal-title":"Cell Discovery"},{"key":"6629_CR57","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1038\/s41467-024-46596-y","volume":"15","author":"S Liu","year":"2024","unstructured":"Liu S, Huang J, Zhou J, Chen S, Zheng W, Liu C, Lin Q, Zhang P, Wu D, He S, Ye J, Liu S, Zhou K, Li B, Qu L, Yang J. NAP-seq reveals multiple classes of structured noncoding RNAs with regulatory functions. Nat Commun. 2024;15:2425.","journal-title":"Nat Commun"},{"key":"6629_CR58","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1016\/j.molcel.2022.05.027","volume":"82","author":"AB Herman","year":"2022","unstructured":"Herman AB, Tsitsipatis D, Gorospe M. Integrated LncRNA function upon genomic and epigenomic regulation. Mol Cell. 2022;82:2252\u201366.","journal-title":"Mol Cell"},{"key":"6629_CR59","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s13046-020-01645-4","volume":"39","author":"K Qiao","year":"2020","unstructured":"Qiao K, Ning S, Wan L, Wu H, Wang Q, Zhang X, Xu S, Pang D. Correction to: LINC00673 is activated by YY1 and promotes the proliferation of breast cancer cells via the miR-515-5p\/MARK4\/Hippo signaling pathway. J Experimental Clin cancer Research: CR. 2020;39:154.","journal-title":"J Experimental Clin cancer Research: CR"},{"key":"6629_CR60","doi-asserted-by":"publisher","first-page":"105520","DOI":"10.1016\/j.phrs.2021.105520","volume":"170","author":"J Lu","year":"2021","unstructured":"Lu J, Huang Y, Zhang X, Xu Y, Nie S. Noncoding RNAs involved in DNA methylation and histone methylation, and acetylation in diabetic vascular complications. Pharmacol Res. 2021;170:105520.","journal-title":"Pharmacol Res"},{"key":"6629_CR61","doi-asserted-by":"publisher","first-page":"4983","DOI":"10.3892\/ol.2017.6769","volume":"14","author":"J Zhang","year":"2017","unstructured":"Zhang J, Li Y, Dong M, Wu D. Long non-coding RNA NEAT1 regulates E2F3 expression by competitively binding to miR-377 in non-small cell lung cancer. Oncol Lett. 2017;14:4983\u20138.","journal-title":"Oncol Lett"},{"key":"6629_CR62","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1158\/0008-5472.CAN-16-1508","volume":"77","author":"P Malakar","year":"2017","unstructured":"Malakar P, Shilo A, Mogilevsky A, Stein I, Pikarsky E, Nevo Y, Benyamini H, Elgavish S, Zong X, Prasanth KV, Karni R. Long noncoding RNA MALAT1 promotes hepatocellular carcinoma development by SRSF1 upregulation and mTOR activation. Cancer Res. 2017;77:1155\u201367.","journal-title":"Cancer Res"},{"key":"6629_CR63","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/s41418-022-00948-7","volume":"29","author":"S Misir","year":"2022","unstructured":"Misir S, Wu N, Yang BB. Specific expression and functions of circular RNAs. Cell Death Differ. 2022;29:481\u201391.","journal-title":"Cell Death Differ"},{"key":"6629_CR64","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1038\/s41467-018-05096-6","volume":"9","author":"RA Wesselhoeft","year":"2018","unstructured":"Wesselhoeft RA, Kowalski PS, Anderson DG. Engineering circular RNA for potent and stable translation in eukaryotic cells. Nat Commun. 2018;9:2629.","journal-title":"Nat Commun"},{"key":"6629_CR65","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12964-024-01494-0","volume":"22","author":"E Heydarnia","year":"2024","unstructured":"Heydarnia E, Dorostgou Z, Hedayati N, Mousavi V, Yahyazadeh S, Alimohammadi M, Gheibi M, Heidari P, Igder S, Mafi A, Vakili O. Circular RNAs and cervical cancer: friends or foes? A landscape on circRNA-mediated regulation of key signaling pathways involved in the onset and progression of HPV-related cervical neoplasms. Cell Communication Signaling: CCS. 2024;22:107.","journal-title":"Cell Communication Signaling: CCS"},{"key":"6629_CR66","doi-asserted-by":"publisher","first-page":"379","DOI":"10.3389\/fpls.2019.00379","volume":"10","author":"W Zhao","year":"2019","unstructured":"Zhao W, Chu S, Jiao Y. Present scenario of circular RNAs (circRNAs) in plants. Front Plant Sci. 2019;10:379.","journal-title":"Front Plant Sci"},{"key":"6629_CR67","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1038\/s12276-024-01220-3","volume":"56","author":"HJ Hwang","year":"2024","unstructured":"Hwang HJ, Kim YK. Molecular mechanisms of circular RNA translation. Exp Mol Med. 2024;56:1272\u201380.","journal-title":"Exp Mol Med"},{"key":"6629_CR68","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1093\/nar\/gkad1138","volume":"52","author":"D Liu","year":"2024","unstructured":"Liu D, Dredge BK, Bert AG, Pillman KA, Toubia J, Guo W, Dyakov BJA, Migault MM, Conn VM, Conn SJ, Gregory PA, Gingras AC, Patel D, Wu B, Goodall GJ. ESRP1 controls biogenesis and function of a large abundant multiexon circrna. Nucleic Acids Res. 2024;52:1387\u2013403.","journal-title":"Nucleic Acids Res"},{"key":"6629_CR69","doi-asserted-by":"publisher","first-page":"10950","DOI":"10.1093\/nar\/gkad763","volume":"51","author":"J Chang","year":"2023","unstructured":"Chang J, Shin MK, Park J, Hwang HJ, Locker N, Ahn J, Kim D, Baek D, Park Y, Lee Y, Boo SH, Kim HI, Kim YK. An interaction between eIF4A3 and eIF3g drives the internal initiation of translation. Nucleic Acids Res. 2023;51:10950\u201369.","journal-title":"Nucleic Acids Res"},{"key":"6629_CR70","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.molcel.2018.06.034","volume":"71","author":"X Li","year":"2018","unstructured":"Li X, Yang L, Chen LL. The biogenesis, functions, and challenges of circular RNAs. Mol Cell. 2018;71:428\u201342.","journal-title":"Mol Cell"},{"key":"6629_CR71","doi-asserted-by":"publisher","first-page":"151286","DOI":"10.1016\/j.ejcb.2023.151286","volume":"102","author":"A Das","year":"2023","unstructured":"Das A, Sinha T, Mishra SS, Das D, Panda AC. Identification of potential proteins translated from circular RNA splice variants. Eur J Cell Biol. 2023;102:151286.","journal-title":"Eur J Cell Biol"},{"key":"6629_CR72","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.molcel.2017.02.021","volume":"66","author":"NR Pamudurti","year":"2017","unstructured":"Pamudurti NR, Bartok O, Jens M, Ashwal-Fluss R, Stottmeister C, Ruhe L, Hanan M, Wyler E, Perez-Hernandez D, Ramberger E, Shenzis S, Samson M, Dittmar G, Landthaler M, Chekulaeva M, Rajewsky N, Kadener S. Translation of circrnas. Mol Cell. 2017;66:9\u2013e217.","journal-title":"Mol Cell"},{"key":"6629_CR73","doi-asserted-by":"publisher","first-page":"16435","DOI":"10.1038\/srep16435","volume":"5","author":"N Abe","year":"2015","unstructured":"Abe N, Matsumoto K, Nishihara M, Nakano Y, Shibata A, Maruyama H, Shuto S, Matsuda A, Yoshida M, Ito Y, Abe H. Rolling circle translation of circular RNA in living human cells. Sci Rep. 2015;5:16435.","journal-title":"Sci Rep"},{"key":"6629_CR74","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1038\/s41388-017-0019-9","volume":"37","author":"M Zhang","year":"2018","unstructured":"Zhang M, Huang N, Yang X, Luo J, Yan S, Xiao F, Chen W, Gao X, Zhao K, Zhou H, Li Z, Ming L, Xie B, Zhang N. A novel protein encoded by the circular form of the SHPRH gene suppresses glioma tumorigenesis. Oncogene. 2018;37:1805\u201314.","journal-title":"Oncogene"},{"key":"6629_CR75","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.cell.2015.02.014","volume":"160","author":"SJ Conn","year":"2015","unstructured":"Conn SJ, Pillman KA, Toubia J, Conn VM, Salmanidis M, Phillips CA, Roslan S, Schreiber AW, Gregory PA, Goodall GJ. The RNA binding protein quaking regulates formation of circrnas. Cell. 2015;160:1125\u201334.","journal-title":"Cell"},{"key":"6629_CR76","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.canlet.2015.06.003","volume":"365","author":"S Qu","year":"2015","unstructured":"Qu S, Yang X, Li X, Wang J, Gao Y, Shang R, Sun W, Dou K, Li H. Circular RNA: A new star of noncoding RNAs. Cancer Lett. 2015;365:141\u20138.","journal-title":"Cancer Lett"},{"key":"6629_CR77","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12943-020-01265-8","volume":"19","author":"J Bi","year":"2020","unstructured":"Bi J, Liu H, Dong W, Xie W, He Q, Cai Z, Huang J, Lin T. Correction to: circular RNA circ-ZKSCAN1 inhibits bladder cancer progression through miR-1178-3p\/p21 axis and acts as a prognostic factor of recurrence. Mol Cancer. 2020;19:148.","journal-title":"Mol Cancer"},{"key":"6629_CR78","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12943-023-01883-y","volume":"22","author":"Z Miao","year":"2023","unstructured":"Miao Z, Li J, Wang Y, Shi M, Gu X, Zhang X, Wei F, Tang X, Zheng L, Xing Y. Hsa_circ_0136666 stimulates gastric cancer progression and tumor immune escape by regulating the miR-375\/PRKDC Axis and PD-L1 phosphorylation. Mol Cancer. 2023;22:205.","journal-title":"Mol Cancer"},{"key":"6629_CR79","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.trecan.2020.01.012","volume":"6","author":"J Li","year":"2020","unstructured":"Li J, Sun D, Pu W, Wang J, Peng Y. Circular RNAs in cancer: biogenesis, function, and clinical significance. Trends cancer. 2020;6:319\u201336.","journal-title":"Trends cancer"},{"key":"6629_CR80","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1158\/2159-8290.CD-23-0530","volume":"14","author":"G Ciriello","year":"2024","unstructured":"Ciriello G, Magnani L, Aitken SJ, Akkari L, Behjati S, Hanahan D, Landau DA, Lopez-Bigas N, Lupi\u00e1\u00f1ez DG, Marine JC, Martin-Villalba A, Natoli G, Obenauf AC, Oricchio E, Scaffidi P, Sottoriva A, Swarbrick A, Tonon G, Vanharanta S, Zuber J. Cancer evolution: A multifaceted affair. Cancer Discov. 2024;14:36\u201348.","journal-title":"Cancer Discov"},{"key":"6629_CR81","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12929-024-00997-9","volume":"31","author":"DB Rodrigues","year":"2024","unstructured":"Rodrigues DB, Reis RL, Pirraco RP. Modelling the complex nature of the tumor microenvironment: 3D tumor spheroids as an evolving tool. J Biomed Sci. 2024;31:13.","journal-title":"J Biomed Sci"},{"key":"6629_CR82","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13148-024-01633-x","volume":"16","author":"D Zhu","year":"2024","unstructured":"Zhu D, Zeng S, Su C, Li J, Xuan Y, Lin Y, Xu E, Fan Q. The interaction between DNA methylation and tumor immune microenvironment: from the laboratory to clinical applications. Clin Epigenetics. 2024;16:24.","journal-title":"Clin Epigenetics"},{"key":"6629_CR83","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3389\/fimmu.2020.00073","volume":"11","author":"GR Rossi","year":"2020","unstructured":"Rossi GR, Trindade ES, Souza-Fonseca-Guimaraes F. Tumor Microenvironment-Associated extracellular matrix components regulate NK cell function. Front Immunol. 2020;11:73.","journal-title":"Front Immunol"},{"key":"6629_CR84","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s13046-024-03115-7","volume":"43","author":"M Hu","year":"2024","unstructured":"Hu M, Deng F, Song X, Zhao H, Yan F. The crosstalk between immune cells and tumor pyroptosis: advancing cancer immunotherapy strategies. J Experimental Clin cancer Research: CR. 2024;43:190.","journal-title":"J Experimental Clin cancer Research: CR"},{"key":"6629_CR85","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41392-024-01786-4","volume":"9","author":"C Silvestre-Roig","year":"2024","unstructured":"Silvestre-Roig C, Kalafati L, Chavakis T. Neutrophils are shaped by the tumor microenvironment: novel possibilities for targeting neutrophils in cancer. Signal Transduct Target Therapy. 2024;9:77.","journal-title":"Signal Transduct Target Therapy"},{"key":"6629_CR86","doi-asserted-by":"publisher","first-page":"4067","DOI":"10.1038\/s41467-024-48310-4","volume":"15","author":"J Kang","year":"2024","unstructured":"Kang J, Lee JH, Cha H, An J, Kwon J, Lee S, Kim S, Baykan MY, Kim SY, An D, Kwon AY, An HJ, Lee SH, Choi JK, Park JE. Systematic dissection of tumor-normal single-cell ecosystems across a thousand tumors of 30 cancer types. Nat Commun. 2024;15:4067.","journal-title":"Nat Commun"},{"key":"6629_CR87","doi-asserted-by":"publisher","first-page":"e57474","DOI":"10.1371\/journal.pone.0057474","volume":"8","author":"SK Leivonen","year":"2013","unstructured":"Leivonen SK, Lazaridis K, Decock J, Chantry A, Edwards DR, K\u00e4h\u00e4ri VM. TGF-\u03b2-elicited induction of tissue inhibitor of metalloproteinases (TIMP)-3 expression in fibroblasts involves complex interplay between Smad3, p38\u03b1, and ERK1\/2. PLoS ONE. 2013;8:e57474.","journal-title":"PLoS ONE"},{"key":"6629_CR88","doi-asserted-by":"publisher","first-page":"102403","DOI":"10.1016\/j.isci.2021.102403","volume":"24","author":"G Ciriello","year":"2021","unstructured":"Ciriello G, Magnani L. The many faces of cancer evolution. iScience. 2021;24:102403.","journal-title":"iScience"},{"key":"6629_CR89","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1158\/0008-5472.CAN-22-1270","volume":"83","author":"X Zheng","year":"2023","unstructured":"Zheng X, Sarode P, Weigert A, Turkowski K, Chelladurai P, G\u00fcnther S, Kuenne C, Winter H, Stenzinger A, Reu S, Grimminger F, Stiewe T, Seeger W, Pullamsetti SS, Savai R. The HDAC2-SP1 Axis orchestrates protumor macrophage polarization. Cancer Res. 2023;83:2345\u201357.","journal-title":"Cancer Res"},{"key":"6629_CR90","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.semcancer.2022.02.010","volume":"86","author":"Y Wang","year":"2022","unstructured":"Wang Y, Wang Y, Ren Y, Zhang Q, Yi P, Cheng C. Metabolic modulation of immune checkpoints and novel therapeutic strategies in cancer. Sem Cancer Biol. 2022;86:542\u201365.","journal-title":"Sem Cancer Biol"},{"key":"6629_CR91","doi-asserted-by":"crossref","unstructured":"Gavish, A., Tyler, M., Greenwald, A. C., Hoefflin, R., Simkin, D., Tschernichovsky,R., Galili Darnell, N., Somech, E., Barbolin, C., Antman, T., Kovarsky, D., Barrett,T., Gonzalez Castro, L. N., Halder, D., Chanoch-Myers, R., Laffy, J., Mints, M., Wider,A., Tal, R., Spitzer, A.,\u2026 Tirosh, I. (2023). Hallmarks of transcriptional intratumour heterogeneity across a thousand tumours.Nature,618, 598\u2013606.","DOI":"10.1038\/s41586-023-06130-4"},{"key":"6629_CR92","doi-asserted-by":"publisher","first-page":"3974","DOI":"10.1158\/0008-5472.CAN-22-0800","volume":"82","author":"H Liu","year":"2022","unstructured":"Liu H, Lyu H, Jiang G, Chen D, Ruan S, Liu S, Zhou L, Yang M, Zeng S, He Z, Wang H, Li H, Zheng G, Liu B. ALKBH5-Mediated m6A demethylation of GLUT4 mRNA promotes Glycolysis and resistance to HER2-Targeted therapy in breast Cancer. Cancer Res. 2022;82:3974\u201386.","journal-title":"Cancer Res"},{"key":"6629_CR93","doi-asserted-by":"publisher","first-page":"978092","DOI":"10.3389\/fimmu.2022.978092","volume":"13","author":"X Shen","year":"2022","unstructured":"Shen X, Zhong J, He J, Han J, Chen N. Identification of m6A modification patterns and development of m6A-hypoxia prognostic signature to characterize tumor microenvironment in triple-negative breast cancer. Front Immunol. 2022;13:978092.","journal-title":"Front Immunol"},{"key":"6629_CR94","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jhep.2015.02.009","volume":"63","author":"Y Liu","year":"2015","unstructured":"Liu Y, Yan W, Tohme S, Chen M, Fu Y, Tian D, Lotze M, Tang D, Tsung A. Hypoxia induced HMGB1 and mitochondrial DNA interactions mediate tumor growth in hepatocellular carcinoma through Toll-like receptor 9. J Hepatol. 2015;63:114\u201321.","journal-title":"J Hepatol"},{"key":"6629_CR95","doi-asserted-by":"publisher","first-page":"153303382110363","DOI":"10.1177\/15330338211036304","volume":"20","author":"Y Li","year":"2021","unstructured":"Li Y, Zhao L, Li XF. Hypoxia and the tumor microenvironment. Technol Cancer Res Treat. 2021;20:15330338211036304.","journal-title":"Technol Cancer Res Treat"},{"key":"6629_CR96","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12943-024-02041-8","volume":"23","author":"Y Li","year":"2024","unstructured":"Li Y, Jin H, Li Q, Shi L, Mao Y, Zhao L. The role of RNA methylation in tumor immunity and its potential in immunotherapy. Mol Cancer. 2024;23:130.","journal-title":"Mol Cancer"},{"key":"6629_CR97","doi-asserted-by":"publisher","first-page":"e104514","DOI":"10.15252\/embj.2020104514","volume":"39","author":"L Wang","year":"2020","unstructured":"Wang L, Hui H, Agrawal K, Kang Y, Li N, Tang R, Yuan J, Rana TM. m6A RNA methyltransferases METTL3\/14 regulate immune responses to anti-PD-1 therapy. EMBO J. 2020;39:e104514.","journal-title":"EMBO J"},{"key":"6629_CR98","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.jhep.2023.06.021","volume":"79","author":"L Wang","year":"2023","unstructured":"Wang L, Zhu L, Liang C, Huang X, Liu Z, Huo J, Zhang Y, Zhang Y, Chen L, Xu H, Li X, Xu L, Kuang M, Wong CC, Yu J. Targeting N6-methyladenosine reader YTHDF1 with SiRNA boosts antitumor immunity in NASH-HCC by inhibiting EZH2-IL-6 axis. J Hepatol. 2023;79:1185\u2013200.","journal-title":"J Hepatol"},{"key":"6629_CR99","doi-asserted-by":"publisher","first-page":"105301","DOI":"10.1016\/j.ebiom.2024.105301","volume":"107","author":"J Liu","year":"2024","unstructured":"Liu J, Bai Y, Li Y, Li X, Luo K. Reprogramming the immunosuppressive tumor microenvironment through nanomedicine: an immunometabolism perspective. EBioMedicine. 2024;107:105301.","journal-title":"EBioMedicine"},{"key":"6629_CR100","doi-asserted-by":"publisher","unstructured":"Safarkhani M, Ahmadi S, Ipakchi H, Saeb MR, Makvandi P, Ebrahimi Warkiani M, et al. Advancements in aptamer-driven DNA nanostructures for precision drug delivery. Adv Sci. (Weinheim Baden-Wurttemberg Germany) 2024;11(26):e2401617. https:\/\/doi.org\/10.1002\/advs.202401617","DOI":"10.1002\/advs.202401617"},{"key":"6629_CR101","doi-asserted-by":"publisher","first-page":"614","DOI":"10.3389\/fimmu.2014.00614","volume":"5","author":"N Wang","year":"2014","unstructured":"Wang N, Liang H, Zen K. Molecular mechanisms that influence the macrophage m1-m2 polarization balance. Front Immunol. 2014;5:614.","journal-title":"Front Immunol"},{"issue":"3","key":"6629_CR102","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2217\/nnm-2020-0353","volume":"16","author":"N Rabiee","year":"2021","unstructured":"Rabiee N, Ahmadi S, Fatahi Y, Rabiee M, Bagherzadeh M, Dinarvand R, Bagheri B, Zarrintaj P, Saeb MR, Webster TJ. Nanotechnology-assisted microfluidic systems: from bench to bedside. Nanomed (London England). 2021;16(3):237\u201358.","journal-title":"Nanomed (London England)"},{"key":"6629_CR103","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.trecan.2017.06.005","volume":"3","author":"H Wang","year":"2017","unstructured":"Wang H, Franco F, Ho PC. Metabolic regulation of Tregs in cancer: opportunities for immunotherapy. Trends cancer. 2017;3:583\u201392.","journal-title":"Trends cancer"},{"key":"6629_CR104","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s42114-023-00825-y","volume":"7","author":"M Safarkhani","year":"2024","unstructured":"Safarkhani M, Ojaghi A, Mirani Nezhad S, Daneshgar H, Paiva-Santos AC, Radmanesh F, Bagherzadeh M, Zare N, Rabiee E, N., Makvandi P. Engineered (NH2)-MIL-125(Ti)\/copolymer@MnFe2O4 nanocomposite for synergistic eradication of cancer cells via DOX\/pCRISPR delivery. Adv Compos Hybrid Mater. 2024;7:18.","journal-title":"Adv Compos Hybrid Mater"},{"key":"6629_CR105","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3389\/fimmu.2017.00248","volume":"8","author":"K Renner","year":"2017","unstructured":"Renner K, Singer K, Koehl GE, Geissler EK, Peter K, Siska PJ, Kreutz M. Metabolic hallmarks of tumor and immune cells in the tumor microenvironment. Front Immunol. 2017;8:248.","journal-title":"Front Immunol"},{"key":"6629_CR106","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.omtn.2019.11.010","volume":"19","author":"S Guo","year":"2020","unstructured":"Guo S, Fesler A, Huang W, Wang Y, Yang J, Wang X, Zheng Y, Hwang GR, Wang H, Ju J. Functional significance and therapeutic potential of miR-15a mimic in pancreatic ductal adenocarcinoma. Mol Therapy Nucleic Acids. 2020;19:228\u201339.","journal-title":"Mol Therapy Nucleic Acids"},{"key":"6629_CR107","doi-asserted-by":"publisher","first-page":"2290033","DOI":"10.1080\/15384047.2023.2290033","volume":"25","author":"Z Liu","year":"2024","unstructured":"Liu Z, Du D, Zhang S. Tumor-derived Exosomal miR-1247-3p promotes angiogenesis in bladder cancer by targeting FOXO1. Cancer Biol Ther. 2024;25:2290033.","journal-title":"Cancer Biol Ther"},{"key":"6629_CR108","doi-asserted-by":"publisher","first-page":"1271603","DOI":"10.3389\/fimmu.2023.1271603","volume":"14","author":"Z Ou","year":"2023","unstructured":"Ou Z, Lu Y, Xu D, Luo Z. Hypoxia mediates immune escape of pancreatic cancer cells by affecting miR-1275\/AXIN2 in natural killer cells. Front Immunol. 2023;14:1271603.","journal-title":"Front Immunol"},{"key":"6629_CR109","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s12964-024-01570-5","volume":"22","author":"JY Choi","year":"2024","unstructured":"Choi JY, Seok HJ, Lee DH, Lee E, Kim TJ, Bae S, Shin I, Bae IH. Tumor-derived miR-6794-5p enhances cancer growth by promoting M2 macrophage polarization. Cell Communication Signalin: CCS. 2024;22:190.","journal-title":"Cell Communication Signalin: CCS"},{"key":"6629_CR110","first-page":"e2304222","volume":"11","author":"Y Feng","year":"2024","unstructured":"Feng Y, Jin C, Wang T, Chen Z, Ji D, Zhang Y, Zhang C, Zhang D, Peng W, Sun Y. The Uridylyl transferase TUT7-Mediated accumulation of Exosomal miR-1246 reprograms TAMs to support CRC progression. Adv Sci (Weinheim Baden-Wurttemberg Germany). 2024;11:e2304222.","journal-title":"Adv Sci (Weinheim Baden-Wurttemberg Germany)"},{"key":"6629_CR111","doi-asserted-by":"publisher","first-page":"100725","DOI":"10.1016\/j.omto.2023.09.001","volume":"31","author":"R Chen","year":"2023","unstructured":"Chen R, Coleborn E, Bhavsar C, Wang Y, Alim L, Wilkinson AN, Tran MA, Irgam G, Atluri S, Wong K, Shim JJ, Adityan S, Lee JS, Overwijk WW, Steptoe R, Yang D, Wu SY. miR-146a inhibits ovarian tumor growth in vivo via targeting immunosuppressive neutrophils and enhancing CD8+ T cell infiltration. Mol Therapy Oncolytics. 2023;31:100725.","journal-title":"Mol Therapy Oncolytics"},{"key":"6629_CR112","doi-asserted-by":"publisher","first-page":"17523","DOI":"10.3390\/ijms242417523","volume":"24","author":"A Pal","year":"2023","unstructured":"Pal A, Ojha A, Ju J. Functional and potential therapeutic implication of MicroRNAs in pancreatic Cancer. Int J Mol Sci. 2023;24:17523.","journal-title":"Int J Mol Sci"},{"key":"6629_CR113","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.7150\/ijbs.96831","volume":"20","author":"F Lu","year":"2024","unstructured":"Lu F, Ye M, Shen Y, Xu Y, Hu C, Chen J, Yu P, Xue B, Gu D, Xu L, Chen L, Ding Y, Bai J, Tian Y, Tang Q. Hypoxic tumor-derived Exosomal miR-4488 induces macrophage M2 polarization to promote liver metastasis of pancreatic neuroendocrine neoplasm through RTN3\/FABP5 mediated fatty acid oxidation. Int J Biol Sci. 2024;20:3201\u201318.","journal-title":"Int J Biol Sci"},{"key":"6629_CR114","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41419-024-06587-9","volume":"15","author":"Y Duan","year":"2024","unstructured":"Duan Y, Zhou M, Ye B, Yue K, Qiao F, Wang Y, Lai Q, Wu Y, Cao J, Wu Y, Wang X, Jing C. Hypoxia-induced miR-5100 promotes exosome-mediated activation of cancer-associated fibroblasts and metastasis of head and neck squamous cell carcinoma. Cell Death Dis. 2024;15:215.","journal-title":"Cell Death Dis"},{"key":"6629_CR115","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1186\/s13046-023-02887-8","volume":"42","author":"J Song","year":"2023","unstructured":"Song J, Liu Q, Han L, Song T, Huang S, Zhang X, He Q, Liang C, Zhu S, Xiong B. Hsa_circ_0009092\/miR-665\/NLK signaling axis suppresses colorectal cancer progression via recruiting TAMs in the tumor microenvironment. J Experimental Clin cancer Research: CR. 2023;42:319.","journal-title":"J Experimental Clin cancer Research: CR"},{"key":"6629_CR116","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1038\/s41388-024-03057-6","volume":"43","author":"J Zhao","year":"2024","unstructured":"Zhao J, Shen J, Mao L, Yang T, Liu J, Hongbin S. Cancer associated fibroblast secreted miR-432-5p targets CHAC1 to inhibit ferroptosis and promote acquired chemoresistance in prostate cancer. Oncogene. 2024;43:2104\u201314.","journal-title":"Oncogene"},{"key":"6629_CR117","doi-asserted-by":"publisher","first-page":"111182","DOI":"10.1016\/j.cellsig.2024.111182","volume":"119","author":"Z Sheng","year":"2024","unstructured":"Sheng Z, Wang X, Ding X, Zheng Y, Guo A, Cui J, Ma J, Duan W, Dong H, Zhang H, Cui M, Su W, Zhang B. Exosomal miRNA-92a derived from cancer-associated fibroblasts promote invasion and metastasis in breast cancer by regulating G3BP2. Cell Signal. 2024;119:111182.","journal-title":"Cell Signal"},{"key":"6629_CR118","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s13014-023-02369-3","volume":"18","author":"J Zhou","year":"2023","unstructured":"Zhou J, Lei N, Tian W, Guo R, Gao F, Fu H, Zhang J, Dong S, Chen M, Ma Q, Li Y, Chang L. Hypoxic tumor cell-derived small extracellular vesicle miR-152-3p promotes cervical cancer radioresistance through KLF15 protein. Radiation Oncol (London England). 2023;18:183.","journal-title":"Radiation Oncol (London England)"},{"key":"6629_CR119","doi-asserted-by":"crossref","unstructured":"Qin X, Guo H, Wang X, Zhu X, Yan M, Wang X, Xu Q, Shi J, Lu E, Chen W, Zhang J. (2019). Exosomal miR-196a derived from cancer-associated fibroblasts confers cisplatin resistance in head and neck cancer through targeting CDKN1B and ING5. Genome biology, 20, 12.","DOI":"10.1186\/s13059-018-1604-0"},{"key":"6629_CR120","first-page":"365","volume":"33","author":"Y Deng","year":"2018","unstructured":"Deng Y, Zhao F, Zhang Z, Sun F, Wang M. Long noncoding RNA SNHG7 promotes the tumor growth and Epithelial-to-Mesenchymal transition via regulation of miR-34a signals in osteosarcoma. Cancer Biother Radiopharm. 2018;33:365\u201372.","journal-title":"Cancer Biother Radiopharm"},{"key":"6629_CR121","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrd.2016.246","volume":"16","author":"R Rupaimoole","year":"2017","unstructured":"Rupaimoole R, Slack FJ. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nature reviews. Drug Discovery. 2017;16:203\u201322.","journal-title":"Drug Discovery"},{"key":"6629_CR122","doi-asserted-by":"publisher","first-page":"4727","DOI":"10.3892\/ol.2017.6052","volume":"13","author":"Z Wang","year":"2017","unstructured":"Wang Z, Yao W, Li K, Zheng N, Zheng C, Zhao X, Zheng S. Reduction of miR-21 induces SK-N-SH cell apoptosis and inhibits proliferation via PTEN\/PDCD4. Oncol Lett. 2017;13:4727\u201333.","journal-title":"Oncol Lett"},{"key":"6629_CR123","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41698-024-00556-3","volume":"8","author":"S Corvigno","year":"2024","unstructured":"Corvigno S, Liu Y, Bayraktar E, Stur E, Bayram NN, Ahumada AL, Nagaraju S, Rodriguez-Aguayo C, Chen H, Vu TC, Wen Y, Liang H, Zhao L, Lee S, Lopez-Berestein G, Sood AK. Enhanced plant-derived vesicles for nucleotide delivery for cancer therapy. NPJ Precision Oncol. 2024;8:86.","journal-title":"NPJ Precision Oncol"},{"key":"6629_CR124","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41392-024-01872-7","volume":"9","author":"P Zhou","year":"2024","unstructured":"Zhou P, Du X, Jia W, Feng K, Zhang Y. Engineered extracellular vesicles for targeted reprogramming of cancer-associated fibroblasts to potentiate therapy of pancreatic cancer. Signal Transduct Target Therapy. 2024;9:151.","journal-title":"Signal Transduct Target Therapy"},{"key":"6629_CR125","doi-asserted-by":"publisher","first-page":"215798","DOI":"10.1016\/j.canlet.2022.215798","volume":"543","author":"J Yang","year":"2022","unstructured":"Yang J, Liu F, Wang Y, Qu L, Lin A. LncRNAs in tumor metabolic reprogramming and immune microenvironment remodeling. Cancer Lett. 2022;543:215798.","journal-title":"Cancer Lett"},{"key":"6629_CR126","doi-asserted-by":"publisher","first-page":"15129","DOI":"10.1038\/ncomms15129","volume":"8","author":"R Jiang","year":"2017","unstructured":"Jiang R, Tang J, Chen Y, Deng L, Ji J, Xie Y, Wang K, Jia W, Chu WM, Sun B. The long noncoding RNA lnc-EGFR stimulates T-regulatory cells differentiation thus promoting hepatocellular carcinoma immune evasion. Nat Commun. 2017;8:15129.","journal-title":"Nat Commun"},{"key":"6629_CR127","doi-asserted-by":"crossref","unstructured":"Xi Q, Yang G, He X, Zhuang H, Li L, Lin B, Wang L, Wang X, Fang C, Chen Q, Yang Y, Yu Z, Zhang H, Cai W, Li Y, Shen H, Liu L, Zhang R. (2024). M6A-mediated upregulation of lncRNA TUG1 in liver cancer cells regulates the antitumor response of CD8+ T cells and phagocytosis of macrophages. Advanced science (Weinheim, Baden-Wurttemberg, Germany), 11, e2400695.","DOI":"10.1002\/advs.202400695"},{"key":"6629_CR128","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s10238-022-00853-w","volume":"23","author":"Y Sahin","year":"2023","unstructured":"Sahin Y. LncRNA H19 is a potential biomarker and correlated with immune infiltration in thyroid carcinoma. Clin Experimental Med. 2023;23:841\u201351.","journal-title":"Clin Experimental Med"},{"key":"6629_CR129","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s11658-024-00612-7","volume":"29","author":"H Ma","year":"2024","unstructured":"Ma H, Weng F, Tong X, Li H, Yao Y, Yuan J. LncRNA TRPM2-AS promotes endometrial carcinoma progression and angiogenesis via targeting miR-497-5p\/SPP1 axis. Cell Mol Biol Lett. 2024;29:93.","journal-title":"Cell Mol Biol Lett"},{"key":"6629_CR130","doi-asserted-by":"publisher","first-page":"3162","DOI":"10.1038\/s41467-020-16966-3","volume":"11","author":"C Wang","year":"2020","unstructured":"Wang C, Li Y, Yan S, Wang H, Shao X, Xiao M, Yang B, Qin G, Kong R, Chen R, Zhang N. Interactome analysis reveals that LncRNA HULC promotes aerobic Glycolysis through LDHA and PKM2. Nat Commun. 2020;11:3162.","journal-title":"Nat Commun"},{"key":"6629_CR131","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3389\/fonc.2020.00363","volume":"10","author":"Z Lan","year":"2020","unstructured":"Lan Z, Yao X, Sun K, Li A, Liu S, Wang X. The interaction between LncRNA SNHG6 and hnRNPA1 contributes to the growth of colorectal Cancer by enhancing aerobic Glycolysis through the regulation of alternative splicing of PKM. Front Oncol. 2020;10:363.","journal-title":"Front Oncol"},{"key":"6629_CR132","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/s41556-019-0299-0","volume":"21","author":"F Chen","year":"2019","unstructured":"Chen F, Chen J, Yang L, Liu J, Zhang X, Zhang Y, Tu Q, Yin D, Lin D, Wong PP, Huang D, Xing Y, Zhao J, Li M, Liu Q, Su F, Su S, Song E. Extracellular vesicle-packaged HIF-1\u03b1-stabilizing LncRNA from tumour-associated macrophages regulates aerobic Glycolysis of breast cancer cells. Nat Cell Biol. 2019;21:498\u2013510.","journal-title":"Nat Cell Biol"},{"key":"6629_CR133","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.canlet.2019.11.021","volume":"469","author":"J He","year":"2020","unstructured":"He J, Li F, Zhou Y, Hou X, Liu S, Li X, Zhang Y, Jing X, Yang L. LncRNA XLOC_006390 promotes pancreatic carcinogenesis and glutamate metabolism by stabilizing c-Myc. Cancer Lett. 2020;469:419\u201328.","journal-title":"Cancer Lett"},{"key":"6629_CR134","doi-asserted-by":"crossref","unstructured":"Jiang T, Qi J, Xue Z, Liu B, Liu J, Hu Q, Li Y, Ren J, Song H, Xu Y, Xu T, Fan R, Song J. (2024). The m6A modification mediated-lncRNA POU6F2-AS1 reprograms fatty acid metabolism and facilitates the growth of colorectal cancer via upregulation of FASN. Molecular cancer, 23, 55.","DOI":"10.1186\/s12943-024-01962-8"},{"key":"6629_CR135","doi-asserted-by":"publisher","first-page":"e52124","DOI":"10.15252\/embr.202052124","volume":"22","author":"L Xin","year":"2021","unstructured":"Xin L, Zhou LQ, Liu C, Zeng F, Yuan YW, Zhou Q, Li SH, Wu Y, Wang JL, Wu DZ, Lu H. Transfer of LncRNA CRNDE in TAM-derived exosomes is linked with cisplatin resistance in gastric cancer. EMBO Rep. 2021;22:e52124.","journal-title":"EMBO Rep"},{"key":"6629_CR136","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.lungcan.2020.06.037","volume":"147","author":"Q Wang","year":"2020","unstructured":"Wang Q, Li X, Ren S, Su C, Li C, Li W, Yu J, Cheng N, Zhou C. HOTAIR induces EGFR-TKIs resistance in non-small cell lung cancer through epithelial-mesenchymal transition. Lung cancer (Amsterdam Netherlands). 2020;147:99\u2013105.","journal-title":"Lung cancer (Amsterdam Netherlands)"},{"key":"6629_CR137","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41597-023-02550-z","volume":"10","author":"Y Gao","year":"2023","unstructured":"Gao Y, Wang X, Dong L, Qu C, Lu Q, Wang P, Xin M, Zheng W, Liu C, Ning S. Identifying immune checkpoint-related LncRNA biomarkers for immunotherapy response and prognosis in cancers. Sci Data. 2023;10:663.","journal-title":"Sci Data"},{"key":"6629_CR138","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/s41577-020-0390-6","volume":"21","author":"D Dersh","year":"2021","unstructured":"Dersh D, Holl\u00fd J, Yewdell JW. A few good peptides: MHC class I-based cancer immunosurveillance and immunoevasion. Nat Rev Immunol. 2021;21:116\u201328.","journal-title":"Nat Rev Immunol"},{"key":"6629_CR139","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41556-021-00672-3","volume":"23","author":"G Li","year":"2021","unstructured":"Li G, Kryczek I, Nam J, Li X, Li S, Li J, Wei S, Grove S, Vatan L, Zhou J, Du W, Lin H, Wang T, Subramanian C, Moon JJ, Cieslik M, Cohen M, Zou W. LIMIT is an Immunogenic LncRNA in cancer immunity and immunotherapy. Nat Cell Biol. 2021;23:526\u201337.","journal-title":"Nat Cell Biol"},{"key":"6629_CR140","doi-asserted-by":"publisher","first-page":"977266","DOI":"10.3389\/fonc.2022.977266","volume":"12","author":"W Guo","year":"2022","unstructured":"Guo W, Liu GM, Guan JY, Chen YJ, Zhao YZ, Wang K, Bai O. Epigenetic regulation of cutaneous T-cell lymphoma is mediated by dysregulated LncRNA MALAT1 through modulation of tumor microenvironment. Front Oncol. 2022;12:977266.","journal-title":"Front Oncol"},{"key":"6629_CR141","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41576-019-0158-7","volume":"20","author":"LS Kristensen","year":"2019","unstructured":"Kristensen LS, Andersen MS, Stagsted LVW, Ebbesen KK, Hansen TB, Kjems J. The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 2019;20:675\u201391.","journal-title":"Nat Rev Genet"},{"key":"6629_CR142","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12943-020-1135-7","volume":"19","author":"M Lei","year":"2020","unstructured":"Lei M, Zheng G, Ning Q, Zheng J, Dong D. Translation and functional roles of circular RNAs in human cancer. Mol Cancer. 2020;19:30.","journal-title":"Mol Cancer"},{"key":"6629_CR143","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12943-020-01208-3","volume":"19","author":"M Xie","year":"2020","unstructured":"Xie M, Yu T, Jing X, Ma L, Fan Y, Yang F, Ma P, Jiang H, Wu X, Shu Y, Xu T. Exosomal circSHKBP1 promotes gastric cancer progression via regulating the miR-582-3p\/HUR\/VEGF axis and suppressing HSP90 degradation. Mol Cancer. 2020;19:112.","journal-title":"Mol Cancer"},{"key":"6629_CR144","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s12943-022-01630-9","volume":"21","author":"T Xie","year":"2022","unstructured":"Xie T, Fu DJ, Li ZM, Lv DJ, Song XL, Yu YZ, Wang C, Li KJ, Zhai B, Wu J, Feng NH, Zhao SC. CircSMARCC1 facilitates tumor progression by disrupting the crosstalk between prostate cancer cells and tumor-associated macrophages via miR-1322\/CCL20\/CCR6 signaling. Mol Cancer. 2022;21:173.","journal-title":"Mol Cancer"},{"key":"6629_CR145","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00262-024-03634-4","volume":"73","author":"Q Liu","year":"2024","unstructured":"Liu Q, Xu P, Jin M, Wang L, Hu F, Yang Q, Bi R, Xiao H, Jiang L, Ding F. CircFTO from M2 macrophage-derived small extracellular vesicles (sEV) enhances NSCLC malignancy by regulation miR-148a-3pPDK4 axis. Cancer Immunol Immunotherapy: CII. 2024;73:91.","journal-title":"Cancer Immunol Immunotherapy: CII"},{"key":"6629_CR146","doi-asserted-by":"publisher","first-page":"1344954","DOI":"10.3389\/fimmu.2024.1344954","volume":"15","author":"D Peng","year":"2024","unstructured":"Peng D, Liang M, Li L, Yang H, Fang D, Chen L, Guan B. Circ_BBS9 as an early diagnostic biomarker for lung adenocarcinoma: direct interaction with IFIT3 in the modulation of tumor immune microenvironment. Front Immunol. 2024;15:1344954.","journal-title":"Front Immunol"},{"key":"6629_CR147","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12943-024-01966-4","volume":"23","author":"C Deng","year":"2024","unstructured":"Deng C, Huo M, Chu H, Zhuang X, Deng G, Li W, Wei H, Zeng L, He Y, Liu H, Li J, Zhang C, Chen H. Exosome circATP8A1 induces macrophage M2 polarization by regulating the miR-1-3p\/STAT6 axis to promote gastric cancer progression. Mol Cancer. 2024;23:49.","journal-title":"Mol Cancer"},{"key":"6629_CR148","doi-asserted-by":"publisher","first-page":"e008491","DOI":"10.1136\/jitc-2023-008491","volume":"12","author":"Z Sun","year":"2024","unstructured":"Sun Z, Xu Y, Shao B, Dang P, Hu S, Sun H, Chen C, Wang C, Liu J, Liu Y, Hu J. Exosomal circpolq promotes macrophage M2 polarization via activating IL-10\/STAT3 axis in a colorectal cancer model. J Immunother Cancer. 2024;12:e008491.","journal-title":"J Immunother Cancer"},{"key":"6629_CR149","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41467-020-20527-z","volume":"12","author":"B Li","year":"2021","unstructured":"Li B, Zhu L, Lu C, Wang C, Wang H, Jin H, Ma X, Cheng Z, Yu C, Wang S, Zuo Q, Zhou Y, Wang J, Yang C, Lv Y, Jiang L, Qin W. circNDUFB2 inhibits non-small cell lung cancer progression via destabilizing IGF2BPs and activating anti-tumor immunity. Nat Commun. 2021;12:295.","journal-title":"Nat Commun"},{"key":"6629_CR150","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41419-022-05540-y","volume":"14","author":"X Yu","year":"2023","unstructured":"Yu X, Tong H, Chen J, Tang C, Wang S, Si Y, Wang S, Tang Z. CircRNA MBOAT2 promotes intrahepatic cholangiocarcinoma progression and lipid metabolism reprogramming by stabilizing PTBP1 to facilitate FASN mRNA cytoplasmic export. Cell Death Dis. 2023;14:20.","journal-title":"Cell Death Dis"},{"key":"6629_CR151","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12943-024-02037-4","volume":"23","author":"Y Liang","year":"2024","unstructured":"Liang Y, Ye F, Luo D, Long L, Wang Y, Jin Y, Wang L, Li Y, Han D, Chen B, Zhao W, Wang L, Yang Q. Exosomal circSIPA1L3-mediated intercellular communication contributes to glucose metabolic reprogramming and progression of triple negative breast cancer. Mol Cancer. 2024;23:125.","journal-title":"Mol Cancer"},{"key":"6629_CR152","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s11658-024-00539-z","volume":"29","author":"W Du","year":"2024","unstructured":"Du W, Quan X, Wang C, Song Q, Mou J, Pei D. Regulation of tumor metastasis and CD8+ T cells infiltration by circRNF216\/miR-576-5p\/ZC3H12C axis in colorectal cancer. Cell Mol Biol Lett. 2024;29:19.","journal-title":"Cell Mol Biol Lett"},{"key":"6629_CR153","doi-asserted-by":"publisher","first-page":"6383","DOI":"10.3390\/ijms25126383","volume":"25","author":"Z Li","year":"2024","unstructured":"Li Z, Yin S, Yang K, Zhang B, Wu X, Zhang M, Gao D. CircRNA regulation of T cells in cancer: unraveling potential targets. Int J Mol Sci. 2024;25:6383.","journal-title":"Int J Mol Sci"},{"key":"6629_CR154","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41586-023-06834-7","volume":"625","author":"D Huang","year":"2024","unstructured":"Huang D, Zhu X, Ye S, Zhang J, Liao J, Zhang N, Zeng X, Wang J, Yang B, Zhang Y, Lao L, Chen J, Xin M, Nie Y, Saw PE, Su S, Song E. Tumour circular RNAs elicit anti-tumour immunity by encoding cryptic peptides. Nature. 2024;625:593\u2013602.","journal-title":"Nature"},{"key":"6629_CR155","doi-asserted-by":"publisher","first-page":"6422","DOI":"10.7150\/thno.77350","volume":"12","author":"H Li","year":"2022","unstructured":"Li H, Peng K, Yang K, Ma W, Qi S, Yu X, He J, Lin X, Yu G. Circular RNA cancer vaccines drive immunity in hard-to-treat malignancies. Theranostics. 2022;12:6422\u201336.","journal-title":"Theranostics"},{"key":"6629_CR156","doi-asserted-by":"publisher","first-page":"16484","DOI":"10.3390\/ijms242216484","volume":"24","author":"T Abaza","year":"2023","unstructured":"Abaza T, El-Aziz MKA, Daniel KA, Karousi P, Papatsirou M, Fahmy SA, Hamdy NM, Kontos CK, Youness RA. Emerging role of circular RNAs in hepatocellular carcinoma immunotherapy. Int J Mol Sci. 2023;24:16484.","journal-title":"Int J Mol Sci"},{"key":"6629_CR157","doi-asserted-by":"publisher","first-page":"114113","DOI":"10.1016\/j.addr.2022.114113","volume":"182","author":"G Kara","year":"2022","unstructured":"Kara G, Calin GA, Ozpolat B. RNAi-based therapeutics and tumor targeted delivery in cancer. Adv Drug Deliv Rev. 2022;182:114113.","journal-title":"Adv Drug Deliv Rev"},{"key":"6629_CR158","doi-asserted-by":"publisher","first-page":"eadp0334","DOI":"10.1126\/sciadv.adp0334","volume":"10","author":"J Xu","year":"2024","unstructured":"Xu J, Zhao X, Liang X, Guo D, Wang J, Wang Q, Tang X. Development of miRNA-based protacs targeting Lin28 for breast cancer therapy. Sci Adv. 2024;10:eadp0334.","journal-title":"Sci Adv"},{"issue":"1","key":"6629_CR159","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s13045-016-0362-2","volume":"9","author":"MP Abruzzese","year":"2016","unstructured":"Abruzzese MP, Bilotta MT, Fionda C, Zingoni A, Soriani A, Vulpis E, Borrelli C, Zitti B, Petrucci MT, Ricciardi MR, Molfetta R, Paolini R, Santoni A, Cippitelli M. Inhibition of bromodomain and extra-terminal (BET) proteins increases NKG2D ligand MICA expression and sensitivity to NK cell-mediated cytotoxicity in multiple myeloma cells: role of cMYC-IRF4-miR-125b interplay. J Hematol Oncol. 2016;9(1):134.","journal-title":"J Hematol Oncol"},{"key":"6629_CR160","doi-asserted-by":"publisher","first-page":"1105173","DOI":"10.3389\/fgene.2022.1105173","volume":"13","author":"G Ajabnoor","year":"2023","unstructured":"Ajabnoor G, Alsubhi F, Shinawi T, Habhab W, Albaqami WF, Alqahtani HS, Nasief H, Bondagji N, Elango R, Shaik NA, Banaganapalli B. Computational approaches for discovering significant MicroRNAs, microRNA-mRNA regulatory pathways, and therapeutic protein targets in endometrial cancer. Front Genet. 2023;13:1105173.","journal-title":"Front Genet"},{"key":"6629_CR161","doi-asserted-by":"publisher","first-page":"6905","DOI":"10.1038\/s41467-023-42740-2","volume":"14","author":"J Yan","year":"2023","unstructured":"Yan J, Ma X, Liang D, Ran M, Zheng D, Chen X, Zhou S, Sun W, Shen X, Zhang H. An autocatalytic multicomponent DNAzyme nanomachine for tumor-specific photothermal therapy sensitization in pancreatic cancer. Nat Commun. 2023;14:6905.","journal-title":"Nat Commun"},{"key":"6629_CR162","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41419-023-06178-0","volume":"14","author":"T Fuertes","year":"2023","unstructured":"Fuertes T, \u00c1lvarez-Corrales E, G\u00f3mez-Escolar C, Ubieto-Capella P, Serrano-Navarro \u00c1, de Molina A, M\u00e9ndez J, Ramiro AR, de Y\u00e9benes VG. miR-28-based combination therapy impairs aggressive B cell lymphoma growth by rewiring DNA replication. Cell Death Dis. 2023;14:687.","journal-title":"Cell Death Dis"},{"issue":"7","key":"6629_CR163","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1158\/0008-5472.CAN-11-3160","volume":"72","author":"JR Cubillos-Ruiz","year":"2012","unstructured":"Cubillos-Ruiz JR, Baird JR, Tesone AJ, Rutkowski MR, Scarlett UK, Camposeco-Jacobs AL, Anadon-Arnillas J, Harwood NM, Korc M, Fiering SN, Sempere LF, Conejo-Garcia JR. Reprogramming tumor-associated dendritic cells in vivo using MiRNA mimetics triggers protective immunity against ovarian cancer. Cancer Res. 2012;72(7):1683\u201393.","journal-title":"Cancer Res"},{"key":"6629_CR164","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s11658-019-0196-3","volume":"24","author":"R Bartoszewski","year":"2019","unstructured":"Bartoszewski R, Sikorski AF. Editorial focus: Understanding off-target effects as the key to successful RNAi therapy. Cell Mol Biol Lett. 2019;24:69.","journal-title":"Cell Mol Biol Lett"},{"key":"6629_CR165","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jconrel.2020.08.028","volume":"327","author":"V Simion","year":"2020","unstructured":"Simion V, Henriet E, Juric V, Aquino R, Loussouarn C, Laurent Y, Martin F, Midoux P, Garcion E, Pichon C, Baril P. Intracellular trafficking and functional monitoring of MiRNA delivery in glioblastoma using lipopolyplexes and the MiRNA-ON RILES reporter system. J Controlled Release: Official J Controlled Release Soc. 2020;327:429\u201343.","journal-title":"J Controlled Release: Official J Controlled Release Soc"},{"key":"6629_CR166","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1038\/s41467-018-04791-8","volume":"9","author":"WM Usman","year":"2018","unstructured":"Usman WM, Pham TC, Kwok YY, Vu LT, Ma V, Peng B, Chan YS, Wei L, Chin SM, Azad A, He AB, Leung AYH, Yang M, Shyh-Chang N, Cho WC, Shi J, Le MTN. Efficient RNA drug delivery using red blood cell extracellular vesicles. Nat Commun. 2018;9:2359.","journal-title":"Nat Commun"},{"key":"6629_CR167","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1161\/CIRCRESAHA.123.322993","volume":"134","author":"S Raju","year":"2024","unstructured":"Raju S, Botts SR, Blaser MC, Abdul-Samad M, Prajapati K, Khosraviani N, Ho TWW, Breda LCD, Ching C, Galant NJ, Fiddes L, Wu R, Clift CL, Pham T, Lee WL, Singh SA, Aikawa E, Fish JE, Howe KL. Directional endothelial communication by polarized extracellular vesicle release. Circul Res. 2024;134:269\u201389.","journal-title":"Circul Res"},{"key":"6629_CR168","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/s12951-024-02559-5","volume":"22","author":"J Hong","year":"2024","unstructured":"Hong J, Sim D, Lee BH, Sarangthem V, Park RW. Multifunctional elastin-like polypeptide nanocarriers for efficient MiRNA delivery in cancer therapy. J Nanobiotechnol. 2024;22:293.","journal-title":"J Nanobiotechnol"},{"key":"6629_CR169","doi-asserted-by":"publisher","unstructured":"Jiang Y, Li S, Shi R, Yin W, Lv W, Tian T, et al. A novel bioswitchable MiRNA mimic delivery system: therapeutic strategies upgraded from tetrahedral framework nucleic acid system for fibrotic disease treatment and pyroptosis pathway inhibition. Adv Sci. (Weinheim Baden-Wurttemberg Germany). 2024;11:e2305622. https:\/\/doi.org\/10.1002\/advs.202305622","DOI":"10.1002\/advs.202305622"},{"key":"6629_CR170","doi-asserted-by":"publisher","first-page":"3088","DOI":"10.1016\/j.ijbiomac.2020.10.104","volume":"165Pt B","author":"AV Samrot","year":"2020","unstructured":"Samrot AV, Sean TC, Kudaiyappan T, Bisyarah U, Mirarmandi A, Faradjeva E, Abubakar A, Ali HH, Angalene JLA, Suresh Kumar S. Production, characterization and application of nanocarriers made of polysaccharides, proteins, bio-polyesters and other biopolymers: A review. Int J Biol Macromol. 2020;165Pt B:3088\u2013105.","journal-title":"Int J Biol Macromol"},{"key":"6629_CR171","doi-asserted-by":"publisher","first-page":"6107","DOI":"10.2147\/IJN.S139687","volume":"12","author":"W Brand","year":"2017","unstructured":"Brand W, Noorlander CW, Giannakou C, De Jong WH, Kooi MW, Park MV, Vandebriel RJ, Bosselaers IE, Scholl JH, Geertsma RE. Nanomedicinal products: a survey on specific toxicity and side effects. Int J Nanomed. 2017;12:6107\u201329.","journal-title":"Int J Nanomed"},{"key":"6629_CR172","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12943-024-01967-3","volume":"23","author":"L Wang","year":"2024","unstructured":"Wang L, Wang X, Zhu X, Zhong L, Jiang Q, Wang Y, Tang Q, Li Q, Zhang C, Wang H, Zou D. Drug resistance in ovarian cancer: from mechanism to clinical trial. Mol Cancer. 2024;23:66.","journal-title":"Mol Cancer"},{"key":"6629_CR173","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s12964-023-01330-x","volume":"21","author":"K Imran","year":"2023","unstructured":"Imran K, Iqbal MJ, Abid R, Ahmad MM, Calina D, Sharifi-Rad J, Cho WC. Cellular signaling modulated by miRNA-3652 in ovarian cancer: unveiling mechanistic pathways for future therapeutic strategies. Cell Communication Signaling: CCS. 2023;21:289.","journal-title":"Cell Communication Signaling: CCS"},{"key":"6629_CR174","doi-asserted-by":"crossref","unstructured":"Wurm, A. A., Brilloff, S., Kolovich, S., Sch\u00e4fer, S., Rahimian, E., Kufrin, V., Bill,M., Carrero, Z. I., Drukewitz, S., Kr\u00fcger, A., H\u00fcther, M., Uhrig, S., Oster, S., Westphal,D., Meier, F., Pf\u00fctze, K., H\u00fcbschmann, D., Horak, P., Kreutzfeldt, S., Richter, D.,\u2026 Glimm, H. (2023). Signaling-induced systematic repression of miRNAs uncovers cancer vulnerabilities and targeted therapy sensitivity. Cell reports. Medicine, 4, 101200.","DOI":"10.1016\/j.xcrm.2023.101200"},{"key":"6629_CR175","doi-asserted-by":"publisher","first-page":"7575","DOI":"10.1038\/s41467-023-43293-0","volume":"14","author":"LD Nguyen","year":"2023","unstructured":"Nguyen LD, Wei Z, Silva MC, Barber\u00e1n-Soler S, Zhang J, Rabinovsky R, Muratore CR, Stricker JMS, Hortman C, Young-Pearse TL, Haggarty SJ, Krichevsky AM. Small molecule regulators of MicroRNAs identified by high-throughput screen coupled with high-throughput sequencing. Nat Commun. 2023;14:7575.","journal-title":"Nat Commun"},{"issue":"3","key":"6629_CR176","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.3390\/ijms25031469","volume":"25","author":"AA Seyhan","year":"2024","unstructured":"Seyhan AA. Trials and tribulations of MicroRNA therapeutics. Int J Mol Sci. 2024;25(3):1469.","journal-title":"Int J Mol Sci"},{"key":"6629_CR177","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s42823-023-00655-4","volume":"34","author":"M Safarkhani","year":"2024","unstructured":"Safarkhani M, Saeb MR, Lee J-H, Huh YS, Rabiee N. Carbon-based nanomaterials for CRISPR\/Cas delivery: A perspective on the design approach. Carbon Lett. 2024;34:387\u201397.","journal-title":"Carbon Lett"},{"key":"6629_CR178","doi-asserted-by":"publisher","first-page":"1255668","DOI":"10.3389\/fimmu.2023.1255668","volume":"14","author":"YD Liu","year":"2023","unstructured":"Liu YD, Chen HR, Zhang Y, Yan G, Yan HJ, Zhu Q, Peng LH. Progress and challenges of plant-derived nucleic acids as therapeutics in macrophage-mediated RNA therapy. Front Immunol. 2023;14:1255668.","journal-title":"Front Immunol"},{"key":"6629_CR179","doi-asserted-by":"publisher","first-page":"103214","DOI":"10.1016\/j.bioorg.2019.103214","volume":"92","author":"X Zhang","year":"2019","unstructured":"Zhang X, Hong R, Chen W, Xu M, Wang L. The role of long noncoding RNA in major human disease. Bioorg Chem. 2019;92:103214.","journal-title":"Bioorg Chem"},{"key":"6629_CR180","doi-asserted-by":"publisher","first-page":"188502","DOI":"10.1016\/j.bbcan.2021.188502","volume":"1875","author":"B Goyal","year":"2021","unstructured":"Goyal B, Yadav SRM, Awasthee N, Gupta S, Kunnumakkara AB, Gupta SC. Diagnostic, prognostic, and therapeutic significance of long non-coding RNA MALAT1 in cancer. Biochim Et Biophys Acta Reviews cancer. 2021;1875:188502.","journal-title":"Biochim Et Biophys Acta Reviews cancer"},{"key":"6629_CR181","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1186\/s12967-023-04394-y","volume":"21","author":"R Pei","year":"2023","unstructured":"Pei R, Zhao L, Ding Y, Su Z, Li D, Zhu S, Xu L, Zhao W, Zhou W. JMJD6-BRD4 complex stimulates LncRNA HOTAIR transcription by binding to the promoter region of HOTAIR and induces radioresistance in liver cancer stem cells. J Translational Med. 2023;21:752.","journal-title":"J Translational Med"},{"key":"6629_CR182","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1016\/j.cell.2018.03.068","volume":"173","author":"SW Cho","year":"2018","unstructured":"Cho SW, Xu J, Sun R, Mumbach MR, Carter AC, Chen YG, Yost KE, Kim J, He J, Nevins SA, Chin SF, Caldas C, Liu SJ, Horlbeck MA, Lim DA, Weissman JS, Curtis C, Chang HY. Promoter of LncRNA gene PVT1 is a Tumor-Suppressor DNA boundary element. Cell. 2018;173:1398\u2013e141222.","journal-title":"Cell"},{"key":"6629_CR183","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.molmed.2018.01.001","volume":"24","author":"G Arun","year":"2018","unstructured":"Arun G, Diermeier SD, Spector DL. Therapeutic targeting of long Non-Coding RNAs in Cancer. Trends Mol Med. 2018;24:257\u201377.","journal-title":"Trends Mol Med"},{"key":"6629_CR184","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1021\/acsami.8b18288","volume":"11","author":"N Gong","year":"2019","unstructured":"Gong N, Teng X, Li J, Liang XJ. Antisense Oligonucleotide-Conjugated Nanostructure-Targeting LncRNA MALAT1 inhibits Cancer metastasis. ACS Appl Mater Interfaces. 2019;11:37\u201342.","journal-title":"ACS Appl Mater Interfaces"},{"key":"6629_CR185","doi-asserted-by":"publisher","first-page":"5950","DOI":"10.1093\/nar\/gky437","volume":"46","author":"L Stojic","year":"2018","unstructured":"Stojic L, Lun ATL, Mangei J, Mascalchi P, Quarantotti V, Barr AR, Bakal C, Marioni JC, Gergely F, Odom DT. Specificity of RNAi, LNA and CRISPRi as loss-of-function methods in transcriptional analysis. Nucleic Acids Res. 2018;46:5950\u201366.","journal-title":"Nucleic Acids Res"},{"key":"6629_CR186","doi-asserted-by":"publisher","first-page":"188899","DOI":"10.1016\/j.bbcan.2023.188899","volume":"1878","author":"A Shabna","year":"2023","unstructured":"Shabna A, Bindhya S, Sidhanth C, Garg M, Ganesan TS. Long non-coding RNAs: fundamental regulators and emerging targets of cancer stem cells. Biochim Et Biophys Acta Reviews cancer. 2023;1878:188899.","journal-title":"Biochim Et Biophys Acta Reviews cancer"},{"key":"6629_CR187","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.apsb.2020.10.001","volume":"11","author":"Y Chen","year":"2021","unstructured":"Chen Y, Li Z, Chen X, Zhang S. Long non-coding RNAs: from disease code to drug role. Acta Pharm Sinica B. 2021;11:340\u201354.","journal-title":"Acta Pharm Sinica B"},{"key":"6629_CR188","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/s41419-023-06220-1","volume":"14","author":"KG Zhu","year":"2023","unstructured":"Zhu KG, Yang J, Zhu Y, Zhu Q, Pan W, Deng S, He Y, Zuo D, Wang P, Han Y, Zhang HY. The microprotein encoded by Exosomal lncAKR1C2 promotes gastric cancer lymph node metastasis by regulating fatty acid metabolism. Cell Death Dis. 2023;14:708.","journal-title":"Cell Death Dis"},{"key":"6629_CR189","doi-asserted-by":"publisher","first-page":"115890","DOI":"10.1016\/j.bcp.2023.115890","volume":"218","author":"I Arab","year":"2023","unstructured":"Arab I, Park J, Shin JJ, Shin HS, Suk K, Lee WH. Macrophage LncRNAs in cancer development: Long-awaited therapeutic targets. Biochem Pharmacol. 2023;218:115890.","journal-title":"Biochem Pharmacol"},{"key":"6629_CR190","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.ymthe.2022.10.006","volume":"31","author":"Y Nan","year":"2023","unstructured":"Nan Y, Luo Q, Wu X, Chang W, Zhao P, Liu S, Liu Z. HCP5 prevents ubiquitination-mediated UTP3 degradation to inhibit apoptosis by activating c-Myc transcriptional activity. Mol Therapy: J Am Soc Gene Therapy. 2023;31:552\u201368.","journal-title":"Mol Therapy: J Am Soc Gene Therapy"},{"key":"6629_CR191","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nrm.2017.104","volume":"19","author":"JD Ransohoff","year":"2018","unstructured":"Ransohoff JD, Wei Y, Khavari PA. The functions and unique features of long intergenic non-coding RNA. Nat Rev Mol Cell Biol. 2018;19:143\u201357.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"6629_CR192","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.semcancer.2022.05.013","volume":"86","author":"H Shaath","year":"2022","unstructured":"Shaath H, Vishnubalaji R, Elango R, Kardousha A, Islam Z, Qureshi R, Alam T, Kolatkar PR, Alajez NM. Long non-coding RNA and RNA-binding protein interactions in cancer: experimental and machine learning approaches. Sem Cancer Biol. 2022;86:325\u201345.","journal-title":"Sem Cancer Biol"},{"key":"6629_CR193","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41586-021-03633-w","volume":"595","author":"MM Elguindy","year":"2021","unstructured":"Elguindy MM, Mendell JT. NORAD-induced pumilio phase separation is required for genome stability. Nature. 2021;595:303\u20138.","journal-title":"Nature"},{"key":"6629_CR194","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/s41592-024-02190-0","volume":"21","author":"JJ Montero","year":"2024","unstructured":"Montero JJ, Trozzo R, Sugden M, \u00d6llinger R, Belka A, Zhigalova E, Waetzig P, Engleitner T, Schmidt-Supprian M, Saur D, Rad R. Genome-scale pan-cancer interrogation of LncRNA dependencies using CasRx. Nat Methods. 2024;21:584\u201396.","journal-title":"Nat Methods"},{"key":"6629_CR195","first-page":"e2309559","volume":"11","author":"J Yuan","year":"2024","unstructured":"Yuan J, Wang Y, Huang Y, Li S, Zhang X, Wu Z, Zhao W, Zhu J, Zhang J, Huang G, Yu P, Cheng X, Wang X, Liu X, Jia J. Investigating novel therapeutic approaches for idiopathic short stature: targeting SiRNA and growth hormone delivery to the growth plate using exosome nanoparticles. Adv Sci (Weinheim Baden-Wurttemberg Germany). 2024;11:e2309559.","journal-title":"Adv Sci (Weinheim Baden-Wurttemberg Germany)"},{"key":"6629_CR196","doi-asserted-by":"publisher","first-page":"103917","DOI":"10.1016\/j.jddst.2022.103917","volume":"78","author":"M Bagherzadeh","year":"2022","unstructured":"Bagherzadeh M, Safarkhani M, Daneshgar H, Radmanesh F, Taghavimandi F, Ghadiri AM, Kiani M, Fatahi Y, Safari-Alighiarloo N, Ahmadi S, Rabiee N. Magnetic carbon\u2013based nanocomposite decorated with palladium complex for co-delivery of DOX\/pCRISPR. J Drug Deliv Sci Technol. 2022;78:103917.","journal-title":"J Drug Deliv Sci Technol"},{"key":"6629_CR197","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s42003-024-05854-x","volume":"7","author":"DM Liang","year":"2024","unstructured":"Liang DM, Li YJ, Zhang JX, Shen HH, Wu CX, Xie N, Liang Y, Li YM, Xue JN, Sun HF, Wang Q, Yang J, Li XH, Wang PY, Xie SY. m6A-methylated KCTD21-AS1 regulates macrophage phagocytosis through CD47 and cell autophagy through TIPR. Commun Biology. 2024;7:215.","journal-title":"Commun Biology"},{"key":"6629_CR198","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1158\/0008-5472.CAN-16-2634","volume":"77","author":"A Bhan","year":"2017","unstructured":"Bhan A, Soleimani M, Mandal SS. Long noncoding RNA and cancer: A new paradigm. Cancer Res. 2017;77:3965\u201381.","journal-title":"Cancer Res"},{"key":"6629_CR199","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","volume":"22","author":"L Statello","year":"2021","unstructured":"Statello L, Guo CJ, Chen LL, Huarte M. Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol. 2021;22:96\u2013118.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"6629_CR200","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nbt.2890","volume":"32","author":"WR Jeck","year":"2014","unstructured":"Jeck WR, Sharpless NE. Detecting and characterizing circular RNAs. Nat Biotechnol. 2014;32:453\u201361.","journal-title":"Nat Biotechnol"},{"key":"6629_CR201","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41580-020-0243-y","volume":"21","author":"LL Chen","year":"2020","unstructured":"Chen LL. The expanding regulatory mechanisms and cellular functions of circular RNAs. Nat Rev Mol Cell Biol. 2020;21:475\u201390.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"6629_CR202","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1007\/s00018-019-03345-5","volume":"77","author":"R Li","year":"2020","unstructured":"Li R, Jiang J, Shi H, Qian H, Zhang X, Xu W. CircRNA: a rising star in gastric cancer. Cell Mol Life Sci. 2020;77:1661\u201380.","journal-title":"Cell Mol Life Sci"},{"key":"6629_CR203","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1080\/15548627.2019.1634945","volume":"16","author":"X Chen","year":"2020","unstructured":"Chen X, Mao R, Su W, Yang X, Geng Q, Guo C, Wang Z, Wang J, Kresty LA, Beer DG, Chang AC, Chen G. Circular RNA circHIPK3 modulates autophagy via MIR124-3p-STAT3-PRKAA\/AMPK\u03b1 signaling in STK11 mutant lung cancer. Autophagy. 2020;16:659\u201371.","journal-title":"Autophagy"},{"key":"6629_CR204","doi-asserted-by":"publisher","first-page":"3526","DOI":"10.7150\/thno.32796","volume":"9","author":"YJ Zhu","year":"2019","unstructured":"Zhu YJ, Zheng B, Luo GJ, Ma XK, Lu XY, Lin XM, Yang S, Zhao Q, Wu T, Li ZX, Liu XL, Wu R, Liu JF, Ge Y, Yang L, Wang HY, Chen L. Circular RNAs negatively regulate cancer stem cells by physically binding FMRP against CCAR1 complex in hepatocellular carcinoma. Theranostics. 2019;9:3526\u201340.","journal-title":"Theranostics"},{"key":"6629_CR205","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12943-019-1060-9","volume":"18","author":"J Bi","year":"2019","unstructured":"Bi J, Liu H, Dong W, Xie W, He Q, Cai Z, Huang J, Lin T. Circular RNA circ-ZKSCAN1 inhibits bladder cancer progression through miR-1178-3p\/p21 axis and acts as a prognostic factor of recurrence. Mol Cancer. 2019;18:133.","journal-title":"Mol Cancer"},{"key":"6629_CR206","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12943-024-02082-z","volume":"23","author":"W Zhang","year":"2024","unstructured":"Zhang W, Xu C, Yang Z, Zhou J, Peng W, Zhang X, Li H, Qu S, Tao K. Circular RNAs in tumor immunity and immunotherapy. Mol Cancer. 2024;23:171.","journal-title":"Mol Cancer"},{"issue":"10","key":"6629_CR207","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.3390\/vaccines11101600","volume":"11","author":"AD Perenkov","year":"2023","unstructured":"Perenkov AD, Sergeeva AD, Vedunova MV, Krysko DV. In vitro transcribed RNA-Based platform vaccines: past, present, and future. Vaccines. 2023;11(10):1600.","journal-title":"Vaccines"},{"key":"6629_CR208","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13062-023-00397-3","volume":"18","author":"J Li","year":"2023","unstructured":"Li J, Dong X, Kong X, Wang Y, Li Y, Tong Y, Zhao W, Duan W, Li P, Wang Y, Wang C. Circular RNA Hsa_circ_0067842 facilitates tumor metastasis and immune escape in breast cancer through HuR\/CMTM6\/PD-L1 axis. Biol Direct. 2023;18:48.","journal-title":"Biol Direct"},{"key":"6629_CR209","doi-asserted-by":"publisher","first-page":"111351","DOI":"10.1016\/j.biopha.2021.111351","volume":"137","author":"J Viralippurath Ashraf","year":"2021","unstructured":"Viralippurath Ashraf J, Sasidharan Nair V, Saleh R, Elkord E. Role of circular RNAs in colorectal tumor microenvironment. Biomed pharmacotherapy = Biomedecine Pharmacotherapie. 2021;137:111351.","journal-title":"Biomed pharmacotherapy = Biomedecine Pharmacotherapie"},{"issue":"16","key":"6629_CR210","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1089\/scd.2021.0059","volume":"30","author":"L Ba","year":"2021","unstructured":"Ba L, Xue C, Li X, Zhang M, Yang Y, Han Q, Sun Z, Zhao RC. Gastric cancer Cell-Derived exosomes can regulate the biological functions of mesenchymal stem cells by inducing the expression of circular RNA circ_0004303. Stem Cells Dev. 2021;30(16):830\u201342.","journal-title":"Stem Cells Dev"},{"key":"6629_CR211","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13045-023-01452-2","volume":"16","author":"F Zhang","year":"2023","unstructured":"Zhang F, Jiang J, Qian H, Yan Y, Xu W. Exosomal circrna: emerging insights into cancer progression and clinical application potential. J Hematol Oncol. 2023;16:67.","journal-title":"J Hematol Oncol"},{"issue":"3","key":"6629_CR212","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1002\/bit.28618","volume":"121","author":"Y Yang","year":"2024","unstructured":"Yang Y, Li J, Li D, Zhou W, Yan F, Wang W. Humanized mouse models: A valuable platform for preclinical evaluation of human cancer. Biotechnol Bioeng. 2024;121(3):835\u201352.","journal-title":"Biotechnol Bioeng"},{"key":"6629_CR213","doi-asserted-by":"crossref","unstructured":"De Crignis, E., Hossain, T., Romal, S., Carofiglio, F., Moulos, P., Khalid, M. M.,Rao, S., Bazrafshan, A., Verstegen, M. M., Pourfarzad, F., Koutsothanassis, C., Gehart,H., Kan, T. W., Palstra, R. J., Boucher, C., IJzermans, J. N., Huch, M., Boj, S. F.,Vries, R., Clevers, H.,\u2026 Mahmoudi, T. (2021). Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma.eLife, 10, e60747.","DOI":"10.7554\/eLife.60747"},{"key":"6629_CR214","doi-asserted-by":"publisher","first-page":"e2302191120","DOI":"10.1073\/pnas.2302191120","volume":"120","author":"L Amaya","year":"2023","unstructured":"Amaya L, Grigoryan L, Li Z, Lee A, Wender PA, Pulendran B, Chang HY. Circular RNA vaccine induces potent T cell responses. Proc Natl Acad Sci USA. 2023;120:e2302191120.","journal-title":"Proc Natl Acad Sci USA"},{"key":"6629_CR215","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12943-023-01759-1","volume":"22","author":"Z Hu","year":"2023","unstructured":"Hu Z, Chen G, Zhao Y, Gao H, Li L, Yin Y, Jiang J, Wang L, Mang Y, Gao Y, Zhang S, Ran J, Li L. Exosome-derived circCCAR1 promotes CD8\u2009+\u2009T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma. Mol Cancer. 2023;22:55.","journal-title":"Mol Cancer"},{"issue":"1","key":"6629_CR216","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1186\/s12967-024-05498-9","volume":"22","author":"Y Li","year":"2024","unstructured":"Li Y, Wang Z, Gao P, Cao D, Dong R, Zhu M, Fei Y, Zuo X, Cai J. CircRHBDD1 promotes immune escape via IGF2BP2\/PD-L1 signaling and acts as a nanotherapeutic target in gastric cancer. J Translational Med. 2024;22(1):704.","journal-title":"J Translational Med"},{"issue":"1","key":"6629_CR217","doi-asserted-by":"publisher","first-page":"9168","DOI":"10.1038\/s41598-022-13297-9","volume":"12","author":"Z Khodaii","year":"2022","unstructured":"Khodaii Z, Mehrabani Natanzi M, Khalighfard S, Ghandian Zanjan M, Gharghi M, Khori V, Amiriani T, Rahimkhani M, Alizadeh AM. Novel targets in rectal cancer by considering lncRNA-miRNA-mRNA network in response to Lactobacillus acidophilus consumption: a randomized clinical trial. Sci Rep. 2022;12(1):9168.","journal-title":"Sci Rep"},{"key":"6629_CR218","doi-asserted-by":"crossref","unstructured":"Hong, D. S., Kang, Y. K., Borad, M., Sachdev, J., Ejadi, S., Lim, H. Y., Brenner,A. J., Park, K., Lee, J. L., Kim, T. Y., Shin, S., Becerra, C. R., Falchook, G., Stoudemire,J., Martin, D., Kelnar, K., Peltier, H., Bonato, V., Bader, A. G., Smith, S.,\u2026 Beg,M. S. (2020). Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours. British journal of cancer, 122(11), 1630\u20131637.","DOI":"10.1038\/s41416-020-0802-1"},{"issue":"1","key":"6629_CR219","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s12885-025-13623-0","volume":"25","author":"S Deguchi","year":"2025","unstructured":"Deguchi S, Ohka F, Shiba Y, Yamaguchi J, Sato A, Shinjo K, Arakawa Y, Narita Y, Kondo Y, Saito R. Investigator-initiated phase I trial of an oligonucleotide therapeutic targeting long noncoding RNA TUG 1 for recurrent glioblastoma. BMC Cancer. 2025;25(1):251.","journal-title":"BMC Cancer"},{"issue":"1","key":"6629_CR220","doi-asserted-by":"publisher","first-page":"6016","DOI":"10.1038\/s41598-021-85237-y","volume":"11","author":"Y Sunagawa","year":"2021","unstructured":"Sunagawa Y, Yamada S, Sonohara F, Kurimoto K, Tanaka N, Suzuki Y, Inokawa Y, Takami H, Hayashi M, Kanda M, Tanaka C, Nakayama G, Koike M, Kodera Y. Genome-wide identification and characterization of circular RNA in resected hepatocellular carcinoma and background liver tissue. Sci Rep. 2021;11(1):6016.","journal-title":"Sci Rep"},{"key":"6629_CR221","doi-asserted-by":"crossref","unstructured":"Tassone, P., Di Martino, M. T., Arbitrio, M., Fiorillo, L., Staropoli, N., Ciliberto,D., Cordua, A., Scionti, F., Bertucci, B., Salvino, A., Lopreiato, M., Thunarf, F.,Cuomo, O., Zito, M. C., De Fina, M. R., Brescia, A., Gualtieri, S., Riillo, C., Manti,F., Caracciolo, D.,\u2026 Tagliaferri, P. (2023). Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study. Journal of hematology & oncology, 16(1), 68.","DOI":"10.1186\/s13045-023-01468-8"},{"key":"6629_CR222","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semcancer.2021.04.010","volume":"75","author":"Y Peng","year":"2021","unstructured":"Peng Y. Non-coding RNAs in human cancer. Sem Cancer Biol. 2021;75:1\u20132.","journal-title":"Sem Cancer Biol"},{"issue":"10","key":"6629_CR223","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1016\/j.ymthe.2019.09.001","volume":"27","author":"J Wang","year":"2019","unstructured":"Wang J, Zhu S, Meng N, He Y, Lu R, Yan GR. ncRNA-Encoded peptides or proteins and Cancer. Mol Therapy: J Am Soc Gene Therapy. 2019;27(10):1718\u201325.","journal-title":"Mol Therapy: J Am Soc Gene Therapy"},{"issue":"11","key":"6629_CR224","doi-asserted-by":"publisher","first-page":"9521","DOI":"10.1007\/s11033-023-08695-9","volume":"50","author":"ES Lobera","year":"2023","unstructured":"Lobera ES, Varela MA, Jimenez RL, Moreno RB. MiRNA as biomarker in lung cancer. Mol Biol Rep. 2023;50(11):9521\u20137.","journal-title":"Mol Biol Rep"},{"key":"6629_CR225","doi-asserted-by":"publisher","first-page":"116683","DOI":"10.1016\/j.bcp.2024.116683","volume":"231","author":"A Balkrishna","year":"2025","unstructured":"Balkrishna A, Mittal R, Bishayee A, Kumar AP, Bishayee A. MiRNA signatures affecting the survival outcome in distant metastasis of triple-negative breast cancer. Biochem Pharmacol. 2025;231:116683.","journal-title":"Biochem Pharmacol"},{"issue":"9","key":"6629_CR226","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1089\/ars.2017.7293","volume":"29","author":"X Wu","year":"2018","unstructured":"Wu X, Tudoran OM, Calin GA, Ivan M. The many faces of long noncoding RNAs in Cancer. Antioxid Redox Signal. 2018;29(9):922\u201335.","journal-title":"Antioxid Redox Signal"},{"issue":"9","key":"6629_CR227","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/s41422-024-00975-8","volume":"34","author":"L Poliseno","year":"2024","unstructured":"Poliseno L, Lanza M, Pandolfi PP. Coding, or non-coding, that is the question. Cell Res. 2024;34(9):609\u201329.","journal-title":"Cell Res"},{"key":"6629_CR228","doi-asserted-by":"publisher","first-page":"qzae023","DOI":"10.1093\/gpbjnl\/qzae023","volume":"22","author":"H Guo","year":"2024","unstructured":"Guo H, Zhang L, Cui X, Cheng L, Zhao T, Wang Y. SCancerRNA: expression at the Single-cell level and interaction resource of Non-coding RNA biomarkers for cancers. Genom Proteom Bioinform. 2024;22:qzae023.","journal-title":"Genom Proteom Bioinform"},{"key":"6629_CR229","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13046-021-01874-1","volume":"40","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Wang D, Peng M, Tang L, Ouyang J, Xiong F, Guo C, Tang Y, Zhou Y, Liao Q, Wu X, Wang H, Yu J, Li Y, Li X, Li G, Zeng Z, Tan Y, Xiong W. Single-cell RNA sequencing in cancer research. J Experimental Clin cancer Research: CR. 2021;40:81.","journal-title":"J Experimental Clin cancer Research: CR"},{"issue":"4","key":"6629_CR230","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.cell.2020.06.032","volume":"182","author":"Y Katzenelenbogen","year":"2020","unstructured":"Katzenelenbogen Y, Sheban F, Yalin A, Yofe I, Svetlichnyy D, Jaitin DA, Bornstein C, Moshe A, Keren-Shaul H, Cohen M, Wang SY, Li B, David E, Salame TM, Weiner A, Amit I. Coupled scRNA-Seq and intracellular protein activity reveal an immunosuppressive role of TREM2 in Cancer. Cell. 2020;182(4):872\u2013e88519.","journal-title":"Cell"},{"issue":"1","key":"6629_CR231","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s13059-019-1812-2","volume":"20","author":"Y Baran","year":"2019","unstructured":"Baran Y, Bercovich A, Sebe-Pedros A, Lubling Y, Giladi A, Chomsky E, Meir Z, Hoichman M, Lifshitz A, Tanay A. MetaCell: analysis of single-cell RNA-seq data using K-nn graph partitions. Genome Biol. 2019;20(1):206.","journal-title":"Genome Biol"},{"key":"6629_CR232","doi-asserted-by":"crossref","unstructured":"S\u00e1nchez-Rivera, F. J., Diaz, B. J., Kastenhuber, E. R., Schmidt, H., Katti, A., Kennedy,M., Tem, V., Ho, Y. J., Leibold, J., Paffenholz, S. V., Barriga, F. M., Chu, K., Goswami,S., Wuest, A. N., Simon, J. M., Tsanov, K. M., Chakravarty, D., Zhang, H., Leslie,C. S., Lowe, S. W.,\u2026 Dow, L. E. (2022). Base editing sensor libraries for high-throughput engineering and functional analysis of cancer-associated single nucleotide variants.Nature biotechnology, 40(6), 862\u2013873.","DOI":"10.1038\/s41587-021-01172-3"},{"key":"6629_CR233","doi-asserted-by":"publisher","DOI":"10.1021\/acsbiomaterials.3c01689","author":"M Safarkhani","year":"2024","unstructured":"Safarkhani M, Farasati Far B, Kim SH, Makvandi P, Park MK, Huh Y, Rabiee N. Advances and challenges of sensing in water using CRISPR-Cas technology. ACS Biomaterials Sci Eng. 2024. https:\/\/doi.org\/10.1021\/acsbiomaterials.3c01689. Advance online publication.","journal-title":"ACS Biomaterials Sci Eng"},{"key":"6629_CR234","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/nrc.2017.99","volume":"18","author":"E Anastasiadou","year":"2018","unstructured":"Anastasiadou E, Jacob LS, Slack FJ. Non-coding RNA networks in cancer. Nat Rev Cancer. 2018;18:5\u201318.","journal-title":"Nat Rev Cancer"},{"key":"6629_CR235","doi-asserted-by":"publisher","first-page":"e1425","DOI":"10.1002\/ctm2.1425","volume":"13","author":"M Alahdal","year":"2023","unstructured":"Alahdal M, Elkord E. Non-coding RNAs in cancer immunotherapy: predictive biomarkers and targets. Clin Translational Med. 2023;13:e1425.","journal-title":"Clin Translational Med"},{"key":"6629_CR236","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s12943-022-01684-9","volume":"21","author":"T Guo","year":"2022","unstructured":"Guo T, Tang XH, Gao XY, Zhou Y, Jin B, Deng ZQ, Hu Y, Xing XF, Li ZY, Ji JF. A liquid biopsy signature of Circulating exosome-derived mRNAs, MiRNAs and LncRNAs predict therapeutic efficacy to neoadjuvant chemotherapy in patients with advanced gastric cancer. Mol Cancer. 2022;21:216.","journal-title":"Mol Cancer"},{"key":"6629_CR237","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41392-020-0194-y","volume":"5","author":"L Liu","year":"2020","unstructured":"Liu L, Wang Q, Qiu Z, Kang Y, Liu J, Ning S, Yin Y, Pang D, Xu S. Noncoding RNAs: the shot callers in tumor immune escape. Signal Transduct Target Therapy. 2020;5:102.","journal-title":"Signal Transduct Target Therapy"},{"key":"6629_CR238","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41573-021-00219-z","volume":"20","author":"M Winkle","year":"2021","unstructured":"Winkle M, El-Daly SM, Fabbri M, Calin GA. Noncoding RNA therapeutics - challenges and potential solutions. Nat Rev Drug Discov. 2021;20:629\u201351.","journal-title":"Nat Rev Drug Discov"},{"key":"6629_CR239","doi-asserted-by":"publisher","unstructured":"Jahangiri S, Rahimnejad M, Nasrollahi Boroujeni N, Ahmadi Z, Motamed Fath P, Ahmadi S, et al. Viral and non-viral gene therapy using 3D (bio)printing. J Gene Med. 2022;24(12):e3458. https:\/\/doi.org\/10.1002\/jgm.3458","DOI":"10.1002\/jgm.3458"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06629-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06629-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06629-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T10:05:49Z","timestamp":1748858749000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06629-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,2]]},"references-count":239,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6629"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06629-6","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,2]]},"assertion":[{"value":"25 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"614"}}